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An epidemic of obesity and associated metabolic disorders affects an 
increasingly young population in Hong Kong. Also, at the onset of puberty, there is a 
rise in growth hormone (GH) level, which promotes growth and reproductive 
adaptation in adolescents, via the insulin-like growth factor-I (IGF-I) pathways. Both 
GH and IGF-I have been reported to be related to body composition and insulin 
actions. We hypothesize that genes in the GH/IGF-I axis are associated with the 
etiology of obesity and related disorders. On the other hand, GH level is affected by 
lifestyle factors, which may be modified by multiple genes. Thus, our study 
investigated the association of these genes with obesity and related metabolic traits, 
as well as the interaction between genetic variants, physical inactivity and dietary 
patterns in Hong Kong Chinese adolescents. 
A cohort of 2,115 adolescents from 14 Hong Kong secondary schools was 
established by the Diabetes Care and Research Group, Department of Medicine and 
Therapeutics, in whom anthropometric and metabolic profiles were established. 
Factor analysis was performed to reduce obesity-related metabolic traits into 5 
factors: body composition, TC+LDL-C, blood pressure, TG+HDL-C and IGF-I 
activity. Eighteen candidate genes relating to GH/IGF-I axis, food intake and energy 
expenditure pathways were selected for study. A total of 136 haplotype-tagging 
single nucleotide polymorphisms (SNPs) were genotyped in 981 random subjects 
from the cohort for association tests with the 5 derived factor scores. 
In addition, a subgroup of 231 subjects, which consisted of 115 cases having 
one or more metabolic syndrome (MES) components and 116 controls, was selected 
iii 
Abstract 
by the Food and Nutritional Science Program, Department of Biochemistry, for 
collecting three days of 24-hour dietary recalls in the years 2004 and 2006. We also 
re-visited 319 random subjects in 2006 for administration of a validated lifestyle 
questionnaire. 
The two-stage genotyping revealed evidence of associations of 9 SNPs in 5 
candidate genes. This included association of 2 SNPs in the growth hormone receptor 
(GHR) gene with body composition and IGF-I activity, 1 in growth 
hormone-releasing hormone receptor (GHRHR) with body composition, 4 in 
insulin-like growth factor-binding protein-3 {IGFBP3) with TG, TC, HDL-C, LDL-C 
and IGF-I activity, 1 in cocaine- and amphetamine-regulated transcript (CART) with 
TC and LDL-C, as well as 1 in proopiomelanocortin (POMC) with blood pressure. 
The functions of the associated SNPs and genes will be discussed. 
The dietary recalls in two years revealed unhealthy dietary patterns among the 
case-control subgroup. The daily diets of both cases and controls were high in fat 
(50% consumed >30% energy from fat) and cholesterol (50% consumed >300 mg), 
low in fiber (95% consumed <24 g) and calcium (90% consumed�Chinese 's RDAs). 
The unhealthy dietary habits and physical inactivity were also supported by the 
lifestyle questionnaire results among the random group of subjects, including 
breakfast skipping, frequent consumption of snacks, meat and fried foods, low 
consumption of milk, fruit and vegetables, as well as a low physical activity level. 
We revealed some associations of genes coding for GH-related pathways in the 
modulation of adiposity among Hong Kong Chinese adolescents. At the same time, 
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the majority of the cohort was observed to have unhealthy diet and lifestyle habits, 
which might further exacerbate their risk for obesity-related metabolic perturbations. 
Further studies on the interactions among these genetic and dietary factors in a larger 
population are needed, in order to better understand the development of obesity and 
related metabolic disorders among the young population in the future so as to find 
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Chapter 1 - Introduction 
Chapter 1 - Introduction 
1.1 Childhood obesity: a worldwide epidemic 
Childhood obesity has reached epidemic levels globally. According to the data 
collated from surveys of young people aged 5-17 years for the World Health 
Organization (WHO) Global Burden of Disease report and extrapolated to countries 
where no data are available, the prevalence of overweight (including obesity) is 
estimated to be approximately 10% in this age range, and the prevalence of obesity to 
be 2-3% (Lobstein et al., 2004). 
The prevalence of excess weight among children is increasing rapidly in both 
developed and developing countries. North America and some European countries 
have the highest prevalence levels, and have shown high year-on-year increases in 
prevalence, at approximately 0.5%-1% increase per annum during the last two 
decades (Lobstein et al, 2003; Tremblay et al., 2002). A number of developing 
countries undergoing rapid socio-economic and nutrition transition are also showing 
a similar trend. For example, the prevalence of overweight and obesity increased 
from 7.7% to 12.4% among the young population in China within a 6-year period 
between 1991 and 1997 (Wang et al, 2002). 
The rising epidemic of childhood obesity is also observed in Hong Kong. An 
epidemiological study in 2002 demonstrated a prevalence of overweight and obesity 
(defined as >120% of sex-specific median body weight-for-height) of 22.4% in 
children and adolescents aged 8 to 15 years (Wong et al.’ 2005), compared to the 
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prevalence of 10.1% among children aged 3 to 18 in a 1993 study (Leung et al, 
1998). A more recent study revealed 11-13% proportion of obesity, using smoothed 
reference percentile charts for waist circumference (WC) and body mass index (BMI) 
for ethnic Chinese children aged 6-12 years (Sung et al, 2007). 
However, differences in prevalence in different populations should be 
interpreted carefully, as the prevalence may vary depending on how obesity is 
defined. For example, in the US, children having body mass index (BMI) between 
the 85th and 95th percentiles of the Center of Disease Control and Prevention (CDC) 
growth charts were defined as at risk for overweight, and those over the 95th 
percentile as obese (Kuczmarski et al.，2000). Whereas the International Obesity 
Task Force (lOTF) reference proposed in the year 2000 were using age- and 
sex-specific BMI cut-off points corresponding to BMIs of 25 and 30 at age 18，based 
on six international populations including Hong Kong (Cole et al.，2000). It has been 
suggested that the lOTF and CDC references give comparable but not identical 
results when calculating overweight (Flegal et al., 2001). 
2 
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1.2 Health consequences of childhood obesity 
Childhood obesity is associated with health problems that range from physical 
to psychosocial problems. These problems result in conditions that vary from 
nonfatal conditions affecting the quality of life to premature death. 
Physical problems 
Obese children and teens have been found to have risk factors for 
cardiovascular disease (CVD), including high cholesterol levels, high blood pressure, 
and abnormal glucose tolerance (Eckel & Krauss, 1998). In a population-based 
sample of 5- to 17-year-olds, almost 60% of overweight children had at least one 
CVD risk factor while 25 percent of overweight children had two or more CVD risk 
factors (Freedman et aL, 1999). 
Type 2 diabetes is increasingly being reported among obese children and 
adolescents (Fagot-Campagna et al, 2001). While diabetes and glucose intolerance, 
a precursor of diabetes, are common health effects of adult obesity, only in recent 
years has type 2 diabetes begun to emerge as a health-related problem among 
children and adolescents (Must & Anderson, 2003). Onset of diabetes in children and 
adolescents can result in advanced complications such as CVD and kidney failure 
, (Must & Anderson, 2003). 
Sleep apnea is another complication of childhood obesity. A study estimated 
that sleep apnea occurs in about 7% of overweight children (Mallory et aL, 1989). 
Sleep apnea is a sleep-associated breathing disorder defined as the cessation of 
breathing during sleep that lasts for at least 10 seconds, resulting in a dramatic fall of 
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blood oxygen level, and is characterized by loud snoring and labored breathing. It 
can cause daytime sleepiness, pulmonary hypertension, heart failure and even sudden 
death. 
Psychosocial Problems 
Some consequences of childhood and adolescent overweight are psychosocial in 
nature. Overweight children and adolescents are targets of early and systematic 
social discrimination (Dietz, 1998). The psychological stress of social stigmatization 
can cause low self-esteem which, in turn, can hinder academic and social functioning, 
and persist into adulthood (Swartz & Puhl, 2003). 
Tracking of childhood obesity into adulthood 
Overweight children and adolescents are more likely to become obese as adults 
(Serdula et cd., 1993; Steinberger et al., 2001). For example, one study found that 
approximately 80% of children who were overweight at aged 10-15 years were 
obese adults at age 25 years (Whitaker et al, 1997). Another study found that 25% of 
obese adults were overweight as children (Freedman et al” 2001). The latter study 
also found that if overweight begins before 8 years of age, obesity in adulthood is 
likely to be more severe. 
4 
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1.3 Determinants of childhood obesity 
Childhood obesity develops when energy intake exceeds energy expenditure. 
The ease of access to energy-rich foods and sedentary lifestyles, as well as other 
environmental factors within home, school and community, has contributed to the 
rising prevalence of childhood obesity. On the other hand, genetic factors influence 
the susceptibility to the obesogenic environment. The interaction of these lifestyle 
and genetic factors possibly modifies various physiological pathways, leading to 
obesity and related metabolic disorders. 
Genetic disposition 
Although people in developed societies share an increasingly homogeneous 
obesogenic environment, there has been a disproportionate increase in the number of 
massively obese people exclusively in certain ethnic groups, such as Pima Indians 
and Pacific Islanders (Diamond, 2003). This suggests a possibility that a subgroup of 
the population is genetically predispose to obesity. 
The "Thrifty gene" hypothesis proposes that genetic traits governing behavioral 
patterns, such as increased appetite to enhance energy intake or reduced physical 
activity to conserve energy, might be conducive to survival during times of hardship 
but become disadvantageous during times of abundance (Neel, 1962). People who 
possess these genes in today's obesogenic environment might be those who 
"over-react", to become not only slightly overweight, but extremely obese (Friedman, 
2003). There is evidences of the positive selection in the last 10,000 years of the 
involvement of many genes in glucose and lipid metabolism, especially in Asian and 
African Ethic groups (Voight et al., 2006). 
5 
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However, some challenge the orthodox hypothesis that famine and food 
shortage are a significant force in molding our genetic predisposition to obesity and 
metabolic syndrome (Benyshek & Watson, 2006; Speakman, 2006). They argue that 
famines are relatively infrequent modem phenomena that involve insufficient 
mortality for thrifty genes to propagate. Rather than food storage per se, the major 
factors causing death during famine are infectious diseases, as reflected by the 
burden of mortality falling disproportionately on the old and the very young who are 
more susceptible to death from these causes. While mortality in post-reproductive 
adults is irrelevant for genetic selection, differential mortality in the very young is 
unlikely to be biased towards the lean individuals because until recently obesity has 
been virtually unknown in this age class. Also, no evidence has been observed of the 
existence of obesity between famines among the modem hunter-gatherer and 
subsistence agriculture populations. 
On the other hand, some suggest inadequacy of the thriftiness hypothesis 
(Watve & Yajnik, 2007). They propose that apart from enhancing fat storage and 
utilization, insulin resistance is a socio-ecological adaptation which mediates a 
transition in reproductive strategy from "r" (large number of offspring with little 
investment in each) to "K" (smaller number of offspring with more investment in 
each) and a transition in sustenance strategy from "stronger to smarter" or "soldier to 
diplomat", i.e. from a relatively more muscle-dependent to a more brain-dependent 
lifestyle. They also postulate that the pathological consequences of obesity and 
metabolic syndrome are likely to be caused by the immune redistribution response 
rather than insulin resistance per se. 
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Obesity in monomorphic and syndromic forms has been well established. The 
causes of some of the monogenic forms of obesity have been elucidated by the 
cloning of the mouse ob gene, as well as genes involved in appetite regulation via the 
leptin-melanocortin pathway, including genes coding for leptin (Montague et al., 
1997) and its receptor (Clement et al., 1998), the a-melanocortin-stimulating 
hormone receptor (MC4R) (Vaisse et al., 1998; Yeo et al, 1998), 
pro-opiomelanocortin (POMC) (Krude et al, 1998) and prohormone convertase-1 
(Jackson et al, 1997). Several rare syndromes caused by discrete genetic defects or 
chromosomal abnormalities, both autosomal and X-linked, are characterized by 
obesity. The most frequent of these syndromes is Prader-Willi syndrome (PWS), an 
autosomal-dominant disorder that is characterized by obesity and hyperphagia 
(Farooqi & 0’Rahmy, 2005). 
In addition, there are high heritability estimates for obesity and related 
quantitative traits including skinfold thickness, waist circumference and fat 
distribution (h^ >0.60)，supporting an important role of genetics in common, 
polygenic obesity (Walley et aL, 2006). 
High energy intake 
Evidence is limited on specific foods or dietary patterns that contribute to 
excessive energy intake in children and teens. However, large portion sizes for food 
and beverages, eating meals away from home, frequent snacking on energy-dense 
foods and consuming beverages with added sugar are often hypothesized as 
contributing to excess energy intake of children and teens (WHO, 2003). Young 
people in Hong Kong now tend to consume energy-dense, nutrient poor fast foods 
because they are cheap, tasty, widely promoted and readily available. Energy-dense 
7 
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foods tend to be high in fat (such as butter, oil and other frying fats), sugar or starch, 
while energy dilute foods such as fruits and vegetables have high water content. 
There is convincing evidence that a high intake of energy-dense foods induces 
weight gain, whereas a high dietary fiber intake helps protect against weight gain 
(WHO, 2003). In the area of consuming sugar-sweetened drinks, evidence is growing 
to suggest an association with increased obesity among children and adolescents 
(Ludwig et al., 2001; Malik et al, 2006; Welsh et al.’ 2005). The association is 
possibly due to high calories of sugar-sweetened drinks (Sherry, 2005). Also, liquid 
forms of energy may be less satiating than solid forms and lead to higher caloric 
intake (DiMeglio, 2000). 
Physical inactivity 
Studies have revealed an inverse relationship between BMI and physical 
activity (Davies et al., 1995; Rising et al., 1994; Schulz & Schoeller, 1994). Children 
and teens in developed countries tend to adopt a sedentary lifestyle because of 
increasing use of public transport, limited recreation areas, and more sedentary 
leisure pursuits. Several studies have found a positive association between the time 
spent on viewing television and increased prevalence of childhood obesity (Crespo et 
al.’ 2001; Gortmaker et al, 1996). Television watching, as well as video games and 
computer use, contribute to physical inactivity among children and adolescents, 
- possibly by displacing their time spent in physical activities, increasing their energy 
consumption through excessive snacking and eating meals in front of the TV or 
computer and lowering their metabolic rates (Francis & Birch, 2006; Robinson et al.’ 
1993;Treuthef al., 2000). 
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1.4 Hormonal dysregulation and obesity 
A unique feature of the adolescent population is their increased growth hormone 
level (GH) at the onset of puberty (Finkelstein et al., 1972; Mauras et al, 1987). In a 
study of 58 healthy prepubertal and late adolescent males and females, there were 2-
to 2.5-fold augmentations which were gender independent in the mean and integrated 
serum GH concentrations in late puberty (Veldhuis et al, 2000). The study also 
revealed a rise of pulsatile GH release in adolescents, due to a 2.25-fold greater GH 
secretory burst mass (Veldhuis et al., 2000). 
Growth hormone (GH), encoded by the gene GHl, is synthesized by 
somatotropic cells of the anterior pituitary gland. GH release is triggered by growth 
hormone-releasing hormone (GHRH) and its cognate receptor (GHRHR). The 
binding of GH to its receptor (GHR) induces the production of insulin-like growth 
factor-I (IGF-I) to stimulate growth in various tissues including bones and muscles 
(Baker et al., 1993; Le Roith et a!., 2001). 
GH decreases body fat mass in both humans and experimental animals, possibly 
by stimulating lipolysis and antagonizing the lipogenic actions of insulin 
(Bohlooly-Y et al, 2005; Etherton, 2000; Frick et al., 2001; Munzer et al., 2001). 
This is supported by the presence of obesity in adults and children with 
GH-deficiency, while GH substitution decreases the fat mass of these subjects 
(Johannsson et al, 1997). In addition, GH secretion is markedly blunted in obese 
individuals (Scacchi et al, 1999). Studies have shown strong relationships between 
parameters of GH secretion and obesity-related variables. In particular, a negative 
correlation was found between BMI and GH half-life, amplitude of GH secretory 
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episodes and the pulsatile component of GH release (Iranmanesh et al, 1991). The 
percentage of body fat is negatively correlated with 24h GH integrated concentration, 
GH amount per burst and GH half-life (Weltman et al” 2001). The vicious cycle of 
decreased GH levels, owing to an increased fat mass, and reduced lipolytic action by 
GH may further worsen obesity status. 
Insulin-like growth factor-I (IGF-I) is mainly expressed in the liver, in addition 
to pancreas, muscle, intestine, kidney, brain and adipose tissue. It binds to its 
receptor (IGF-IR) to stimulate growth. Circulating IGF-I is stabilized by forming 
complex with IGF-binding proteins (IGFBPs), among which IGFBP-3 is the most 
predominant during postnatal life, and the acid-labile subunit (ALS). 
The metabolic effects of IGF-I on cellular glucose, amino acid uptake, glycogen 
synthesis, lipogenesis and mitogenesis are similar to those of insulin (Hussain et al， 
1993). IGF-I inhibits GH synthesis and release by negative feedback (Hartman et al, 
1993). Hence, it is possible that increased IGF-I is a cause of obesity, due to its 
insulin-like actions to promote energy and lipid storage, as well as its increased 
negative feedback on GH, in which the latter promotes lipolysis. 
The dynamic activity of the GH/IGF-I axis is modulated by various factors 
including age, gender, fitness and fatness (Clasey et al.，2001; Kasa-Vubu et al.’ 
2006). Therefore, genes and pathways that regulate food intake and physical activity 
are likely to interact with the GH/IGF-I axis, leading to changes in obesity-related 
metabolic traits (Figure 1.1). 
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Figure 1.1: Pathways of hormonal dysregulation and obesity 
Ghrelin, encoded by the GHRL gene, is a 28-amino residue peptide 
predominantly produced by the stomach. Ghrelin displays strong GH-releasing 
activity via the growth hormone secretagogue receptor (GHSR). An additive or true 
synergistic effect of ghrelin on GHRH-stimulated GH has been reported 
(Tannenbaum & Bowers，2001). Ghrelin can also antagonize the inhibitory action of 
somatostatin (SS) on GH release (Tannenbaum et al.’ 2003). 
Apart from its GH-releasing action, ghrelin's stimulatory effect on food intake 
is well documented. Ghrelin increases food intake through stimulation of 
pro-opiomelanocortin (POMC)/cocaine- and amphetamine-regulated transcript 
(CART) neurons and inhibition of neuropeptide Y (NPY)/agouti related protein 
homolog (AGRP) neurons in the arcuate nucleus of the hypothalamus (Bell et al, 
2005). The orexigenic signal is then sent to effector neurons expressing the 
melanocortin 4 receptor (MC4R) which in turn leads to decreased food intake. Based 
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on current knowledge, it is speculated that ghrelin ensures that sufficient amounts of 
energy are acquired for GH to promote growth and repair (van der Lely et al, 2004). 
Leptin (LEP) is an adipocyte-specific hormone that regulates adiposity through 
its effects on satiety and energy expenditure by binding to its receptor (LEPR). In 
contrast to ghrelin, leptin decreases food intake through stimulation of NPY/AGRP 
neurons and inhibition of POMC/CART neurons (Bell et al, 2005). The 
anorexigenic signal, again, is received by MC4R and in turn causes reduced food 
consumption. 
As GH also takes part in body composition regulation through its lipolytic effect, 
any interaction between leptin and GH is not unexpected. In fact, both in vivo and in 
vitro studies show that leptin has direct stimulatory effect on GH release, which 
appears to be mediated by GHRH and SS (Cairo et al.’ 1997; Quintela et al., 1997). 
It is plausible that leptin may reinforce its own biological effects, chiefly the 
regulation of body fat, by favoring GH secretion (Scacchi et al, 1999). 
Uncoupling proteins (UCPs) play an important role in generating heat and 
burning calories by creating a pathway that allows dissipation of the proton gradient 
across the inner mitochondrial membrane. Proton leaks constitute a considerable part 
of the resting metabolic rate (RMR)，which contributes to 60-70% percent of total 
energy expenditure (Rolfe et al.，1999). Variations in energy expenditure predict 
body weight changes (Saltzman & Roberts, 1995). Therefore, UCPs are important 
obesity candidate genes. 
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UCPl is found exclusively in brown adipose tissue which is uncommon in 
humans. UCP2 is expressed in most tissues especially the white adipose tissue. 
UCP3 is predominantly expressed in skeletal muscle. UCP2 has been shown to 
inhibit glucose-induced insulin secretion (Lameloise et al, 2001; Zhang et al., 2001). 
UCP3 gene expression was found to correlate negatively with BMI and positively 
with resting metabolic rate in Pima Indians, who had a very high prevalence rate of 
obesity and diabetes (Calsbeek et al., 2002; Kimm et al, 2002). Significant linkages 
have been found between UCP2-UCP3 clusters and energy metabolism in certain 
populations, and associations of these two genes with obesity and type 2 diabetes 
have also been frequently reported (Dalgaard & Pedersen, 2001; Krauss et al., 2005; 
Schrauwen & Hesselink, 2002). 
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1.5 Project objectives and long term significance 
In this study, we aimed to investigate the association of single nucleotide 
polymorphisms (SNPs) in GH-related candidate genes with obesity-related metabolic 
traits among Hong Kong Chinese adolescents. Additionally, we aimed to explore the 
interaction of genetic and lifestyle factors on the modification of obesity phenotypes 
among the population. We hypothesized that genes involved in the GH/IGF-I axis, as 
well as food intake and energy expenditure pathways, may modulate obesity in 
adolescents. The identification of genetic markers and their independent and 
interacting effects with lifestyle factors for obesity and related metabolic disorders in 
Hong Kong adolescents will provide important information on the pathogenesis of 
related diseases. This information will enable early diagnosis and exploration of 
novel therapeutics measures. 
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Chapter 2 - Research Plan and Methodology 
2.1 Study cohort 
A community-based cohort of Hong Kong Chinese adolescents was recruited 
from February 2003 to December 2003 for an epidemiological study by the Diabetes 
Research Group, Department of Medicine and Therapeutics, The Chinese University 
of Hong Kong (Ozaki et al, 2007). All studies done in this cohort are summarized in 
Figures 2.1 & 2.2. 
2.1.1 Subject recruitment 
A full list of all Chinese secondary schools in Hong Kong was obtained from 
the Hong Kong Education Department. Using a computer-generated coding system, 
the research group randomly selected schools from each of the three geographical 
regions, Hong Kong Island, Kowloon and New Territories, to obtain a representative 
sample population of Hong Kong Chinese adolescents. Amongst a total of 477 
schools, 53 schools were selected. Letters were sent to principals of the selected 
schools to explain the rationale and design of the study. Of the 53 schools selected, 
14 schools consented and were recruited into this study. From each participating 
school, 6 classes (Form 1 to Form 6，equivalent to Year 7 to Year 12 in the United 
States) were randomly selected with one class from each Form to obtain a 
proportional number of healthy subjects aged 12-20 years of age. Non-Chinese 
subjects, as well as those with chronic illnesses such as diabetes with or without 
medications were excluded from the study. Upon approval by school principals, 
letters were sent to parents of all selected school children explaining the nature of the 
screening program ensuring minimal interruption to normal school activities. Of the 
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identified random sample of 4598 students, 2115 school children consented and were 
enrolled into the study, giving a response rate of 46%. 
2.1.2 Ethics 
This study was approved by the Clinical Research Ethics Committee (CREC) of 
The Chinese University of Hong Kong. Informed consent was obtained from all 
participants together with their parents' informed and written consent before they 
were enrolled into the study. All the personal information from the subjects was kept 
confidential and not disclosed to anyone not involved in this study. 
2.1.3 Measurements and blood sample collections 
Anthropometric measurements and blood samples were collected from each 
participant by a team of research nurses visiting each school during an allocated time 
in the morning. 
Anthropometric measurements 
Body height and weight were measured in all subjects wearing light clothing 
and without shoes. Height was measured to the nearest 0.1 cm using a portable 
stadiometer, with the subjects standing up straight on the foot plate, heels together 
and touching the backstop, and head positioned so that the head piece (the measuring 
arm) was horizontal. Weight was measured to the nearest 0.1 kg using a Tanita 
physician digital scale. Body mass index (BMI) was calculated as weight (kg) + 
height (m)2. 
Waist circumference (WC) was taken as the minimum circumference between 
the umbilicus and xiphoid process. Hip circumference (HC) was measured at 
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maximal protrusion of the buttocks. The circumferences are given as the mean of two 
measurements to the nearest 0.1 cm. Waist-to-height ratio (WHtR) was calculated as 
WC (cm) + height (cm). Waist-to-hip (WHR) ratio was calculated as WC (cm) + HC 
(cm) 
Percentage body fat was determined by a bioelectrical impedance analyzer. Fat 
mass index (FMI) and fat-free mass index (FFMI) were calculated as follow: 
FM = weight (kg) x body fat (%) 
FMI = FM (kg) + height (m)^ 
FFMI = (total weight - FM) + height (m)^ 
Blood pressure measurements 
Blood pressure (BP) was taken from the non-dominant arm after at least 5 
minutes of sitting using an Omron electronic sphygmomanometer. The Korotkoff 
sound I was taken as the systolic blood pressure (SBP) and the Korotkoff sound V was 
taken as the diastolic blood pressure (DBP). The BP was rechecked after 5 minutes if 
the initial reading was elevated (>140/90 mmHg). The average of the 2 readings was 
used for analysis. 
Blood sample collection 
Fasting blood samples were collected for measurement of biochemistry 
including plasma glucose (FPG), insulin (FINS), total cholesterol (TC), triglyceride 
(TG), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein 
cholesterol (LDL-C), as well as hormonal measurements including insulin-like 
growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3). Subjects were advised 
to fast for at least 8 hours before attending the session for measurement of 
17 
Chapter 2 - Research Plan and Methodology 
anthropometric indices and blood collection. Fasting state was affirmed before blood 
taking by direct questioning. All blood samples were kept in ice at 0°C before they 
were transported back to laboratory for further processing, in which they were then 
assayed within 6 hours after collection or stored at -70�C. 
Biochemical measurements 
Plasma glucose (FPG) was measured by a hexokinase method (Hitachi 911， 
analyzer Boehringer Mannheim, Mannheim, Germany). Both the intra-assay and 
inter-assay coefficients of variation (CV) for glucose were 2% at 6.6 mmol/L. Insulin 
(FINS) was measured by enzyme-linked immunosorbent assay (Dako Diagnostics, 
Gloustrup, Denmark). Homeostasis model assessment for insulin resistance 
(HOMA-IR) was calculated as fasting insulin (mU/1) x FPG (nmol/l) + 22.5. TC and 
TG were assayed enzymatically with commercial reagents (Baker Instruments 
Corportaion, Allentown, PA, USA) on a Cobas Mira analyzer (Hoffmann-La Roche 
and Co, Basle, Switzerland). HDL-C and its subfractions were determined after 
fractional precipitation with dextran sulphate-MgC12, using a Hitachi 911 automated 
analyzer (Boehringer Mannheim, Mannheim, Germany). LDL-C was calculated 
using the Friedewald's formula. Sera were assayed for IGF-I and IGFBP-3 by an 
automated chemiluminescent assay system (IMMULITE 2000，Diagnostic Products 
Corp., Los Angeles, CA, USA). 
2.1.4 Subgroup for dietary assessment 
A subset of 231 subjects, consisting of 115 cases having one or more metabolic 
syndrome (MES) components, and 116 controls having none of the MES 
components, was selected from the cohort by the Diabetes Research Group for 
further blood analyses in 2003. From May 2004 to September 2004 this subgroup 
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also underwent three-day 24-hour dietary recalls by a research team of the Food and 
Nutritional Science Programme, The Chinese University of Hong Kong. 
The definition of MES components was based on the National Cholesterol 
Education Program (NCEP) Adult Treatment Panel III (ATP III) described in the 
recent National Health & Nutrition Examination Survey (NHANES) survey with 
modifications (Cook et al., 2003), which included high TG (>1.24 mmol/1), low 
HDL-C (>1.03 mmol/1), central obesity (WC >90 percentile value for age and sex), 
hypertension (blood pressure >90 percentile value for age, sex and height) and 
impaired glycaemia (FPG >6.1 mmol/1). 
2.1.5 Cohort re-visits in 2006 
A two-phase re-visit of the cohort was carried out in 2006 for longitudinal clinical 
and biochemical measurements, as well as for dietary assessment (Figures 2.1 & 2.2). 
A consent form for this re-visit is shown in Appendix F. 
In the first phase, which took place from July 2006 to August 2006, the 
subgroup of 231 subjects was re-called, in which 129 subjects consented (58% 
response rate). The three-day 24-hour dietary recalls were also administered again by 
the researchers, as discussed in Section 2.3.1. 
In the second phase, which took place from September 2006 to April 2007，the 
randomly selected 981 subjects for genetic study (see Section 2.2.1) were re-called, in 
which 319 subjects consented (32.5% response rate). These subjects were also asked 
to complete a lifestyle questionnaire. Procedures of the lifestyle questionnaire 
assessment will be discussed in Section 2.3.2. 
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Re-visit (Jul 06 - Apr 07) 
-Measurements & blood collection 
Feb 03 - Dec 03: May 04 - Aug 04: 
Phase I: July 06 - Aug 06 
-Subject recruitment Three-day 24-hr dietary 
Case-control subgroup (n=129) 
(n=2,115) recalls in case-control 
-Dietary recalls 
-Anthropometric, subgroup (n=231) 
Phase II: Sept 06 - Apr 07 
biochemical, hormonal 




Genetic study (n=981) _ ^ 
< • <~~• ---• 
• 
2003 2004 2005 2006 2007 
Figure 2.1: Timeline for this study 




2004 Dietary Recalls 2004 Dietary Recalls 
Y N Y N 
n=102 n=129 n=852 
2006 Dietary Recalls 2006 Dietary Recalls Lifestyle questionnaire 
Y N Y N Y N 
n=52 n=77 n=308 
Figure 2.2: Summary of subject numbers involved in the genetic, dietary and lifestyle 
studies 
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2.2 Genetic study 
2.2.1 Sample size estimation and research subjects 
Sample size estimation for genotyping was done using the Genetic Power 
Calculator (Purcell et al,, 2003). Considering a marker allele in linkage 
disequilibrium (r^) of 0.8 to a quantitative trait locus (QTL), the sample size required 
to attain 80% power at alpha level of 0.05 would be 389 and 781 respectively, if the 
QTL accounts for 2% and 1% of the total trait variance under an additive model. 
Taking additional 20% variability into consideration, around 1,000 random samples 
were selected from the cohort to detect at least 1% of trait variance. We compared 
the clinical and biochemical measurements of the random samples with that of the 
imselected samples to ensure that these random samples could represent the study 
cohort. 
The genetic study was performed using a two-stage design, with half of the 
random sample genotyped in stage 1 and the remaining half in stage 2. Again, the 
clinical and biochemical measurements of subjects in the two stages should be 
comparable, to ensure the reproducibility of association results. 
2.2.2 DNA samples 
Extraction by standard phenol / chloroform method 
Chemicals and Reagents 
• lOx lysis buffer: 
0.1 M KHCO3, 0.15 M NH4CI and 1 mM EDTA in extra pure water 
Ix lysis buffer was prepared for extraction 
• 10% SDS (sodium dodecyl sulfate): 
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10% (w/v) SDS in extra pure water 
• 20 mg/ml Proteinase K solution, RNA grade (Invitrogen) 
• Phenol，ultra pure, TE equilibrated to pH 8.0(USB) 
• TE buffer (pH 7.5): 
1 M Tris (pH 7.5) and 0.5 M EDTA (pH 8.0) in extra pure water 
Procedures 
3 ml of anti-coagulated blood sample was centrifuged at 3,000 rpm, 4 °C for 10 
min and the plasma was aspirated off. 10 ml of lysis buffer was added to the blood 
cells, and the sample was placed on ice for 15 min, then centrifuged at 3,000 rpm, 
4°C for 15 min. The supernatant was decanted, and the cell pellet was re-suspended 
in 10 ml of lysis buffer. The ice incubation, centrifugation and decantation steps were 
then repeated. 3 ml of TE buffer, 300 |il of 10% SDS and 20 of proteinase K 
solution were added to the cell pellet, and the sample was incubated at 65 °C water 
bath overnight. 1 ml of 6 M NaCl was added to the overnight digested sample with 
vigorous shaking for a few seconds, and the sample was centrifuged at 3,000 rpm, 4 
°C for 10 min. The supernatant was decanted to a clean test tube. 1 ml of TE 
equilibrated phenol and 1 ml of chloroform were added, and the sample was mixed 
by inversion 5 times. The mixture was centrifuged at 3,000 rpm, 4 °C for 10 min and 
the upper aqueous layer was transferred to a new test tube. 2 ml of chloroform was 
added and mixed well. Then it was centrifuged at 3000 rpm, 4 °C for 10 min and the 
upper aqueous layer was transferred to a new test tube. Two volumes of ice-cold 
absolute ethanol were added for precipitation of DNA. After centrifuging at 3,000 
rpm, 4 °C for 10 min, and the supernatant was decanted. The DNA pellet was then 
washed with 1 ml of 70% ethanol, with centrifugation at 3,000 rpm at 4 °C for 10 
xnin. The alcohol was drained off, and then the DNA was re-suspended with 200 |il 
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of TE buffer. The amount of DNA in each sample was quantified by reading 
absorbance at 260 nm using a spectrometer. The purity of the DNA was checked by 
the ratio of 260 nm/280 nm absorbance. A ratio of 1.8 was regarded as good quality. 
Quantification by Quant-iT Assays 
Chemicals and Reagents 
• Quant-iT dsDNA BR Assay Kit (Invitrogen): 
- Q u a n t - i T dsDNA BR reagent: 200X concentrate in DMSO 
- Q u a n t - i T dsDNA BR buffer 
- Q u a n t - i T dsDNA BR standards: 
0, 5，10, 20，40, 60, 80 and 100 ng/|al in TE buffer 
Procedures 
The Quant-iT assay is highly selective for double-stranded DNA (dsDNA) over 
RNA, and is accurate for initial sample concentration from 100 pg/|j,l to 1,000 ng/|j,l, 
making it suitable for sample quantification for genotyping technologies such as 
Sequenom. 
To fit the optimum range of concentration for quantification, each DNA sample 
was firstly diluted to 100 ng/|j,l in extra pure water according to concentration 
derived from OD measurement. Based on the manufacturer's protocol with 
modifications, the working solution was made by diluting the Quan-iT reagent 1:200 
in Quan-iT buffer in a clean 2 ml micro-tube. To quantify 96 DNA samples 
(including the 8 standards), for example, the working solution was prepared by 
adding 10 [i\ of the Quan-iT reagent and 1,990 of the Quan-iT buffer, to ensure 
enough working solution of 20 for each sample and standard. 19 pi of the working 
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solution was then loaded into each well of a fast 96-well PGR plate (Applied 
Biosystems), followed by 1 |il of each standard and sample, making the final volume 
in each well to be 20 The assay plate was mixed by vortexing for 2-3 seconds, 
and then covered using an optical adhesive cover (Applied Biosystems). The 
fluorescence signal emitted by each well was read by the Fast Real-Time 7500 PCR 
System provided by Applied Biosystems, following the manufacturer's instruction. A 
reference curve of fluorescence intensity against concentrations of the standards was 
then plotted, so that the concentration of each sample could be calculated using the 
equation of the curve. 
2.2.3 Candidate genes 
As described in the introduction, candidate genes for adiposity including those 
involved in pathways of growth hormone metabolism, regulation of appetite and 
energy expenditure were chosen for study after a search of the literature for genes 
that has been reported associated with metabolic syndrome or likely to be associated 
with metabolic syndrome due to its function, as listed in Table 2.1. 
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Table 2.1: Candidate genes selected for association study 
Symbol Gene name Pathway 
GHl Growth hormone GH/IGF-I axis 
GHR Growth hormone receptor GH/IGF-I axis 
Growth hormone-releasing hormone 
GHRHR ^ GH/IGF-I axis 
receptor 
IGFl Insulin-like growth factor-I GH/IGF-I axis 
IGFIR Insulin-like growth factor-I receptor GH/IGF-I axis 
IGFALS Acid labile subunit GH/IGF-I axis 
Insulin-like growth factor binding 
IGFBP3 GH/IGF-I axis 
protein-3 
LEP Leptin Food intake (anorexigenic) 
LEPR Leptin receptor Food intake (anorexigenic) 
NPY Neuropeptide Y Food intake (anorexigenic) 
AGRP Agouti related protein homolog Food intake (anorexigenic) 
GHRL Ghrelin Food intake (orexigenic) 
GHSR Growth hormone secretagogue receptor Food intake (orexigenic) 
POMC Pro-opiomelanocortin Food intake (orexigenic) 
Cocaine- and amphetamine-regulated . 
CART Food intake (orexigenic) 
transcript 
MC4R Melanocortin 4 receptor Food intake 
UCP2 Uncoupling protein 2 Energy expenditure 
UCP3 Uncoupling protein 3 Energy expenditure 
2.2.4 SNP tagging and prioritizing 
As described by Thorisson et al (2005), information about SNPs relevant to the 
Han Chinese population (Data Release #2la/ Phase II July 2006, on NCBI Build #35 
assembly, dbSNP bl25) was firstly retrieved from the Genome Browser of the 
International HapMap Project (available at http://www.hapmap.org) (Figure 2.3). In 
the "Landmark or Region" search box of the start page, the chromosomal position of 
each selected candidate gene was filled in. The 2kb regions upstream and 
downstream of the gene were also included, so that some of the regulatory regions 
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flanking the gene could also be tested for association. The "Dump SNP genotype 
data" item in the "Reports and Analysis" menu was then selected. This generated a 
space-delimited text dump of the genotype results across the selected region, which 
consisted of information including dbSNP ID, the reference and alternative allele, 
position on the genome, and the genotypes of the SNPs on each of the individuals in 
the selected HapMap population. 
The retrieved HapMap data file was loaded into the Haploview program (Barrett 
et al.，2005). Common tagging SNPs with minor allele frequency (MAF) > 0.05 were 
selected by Tagger implemented by the program (Figure 2.4), using the pairwise 
tagging method and r^ cutoff of 0.8, so that they had sufficient power to represent 
most of the common SNPs captured within the candidate region (de Bakker et al., 
2005; Zeggini et al, 2005). SNPs located at the coding regions of a candidate gene, 
e.g. non-synonymous (missense) variants that alter an amino acid in a protein, or a 
nonsense change that resulted in a premature stop codon, as well as those having 
reported association with obesity related phenotypes were given the highest priority 
for genotyping (Tabor et al.’ 2002). This was done by ticking the box 
"force-included" next to the targeted SNPs in the program. Non-HapMap SNPs 
showing previous association with obesity- and/or growth hormone-related traits 
were also studied. 
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Figure 2.3: HapMap Genome Browser displaying target genomic region. Adopted 
from Thorisson et al. (2005). 
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Figure 2.4: Tagger program implemented in Haploview. 
2.2.5 Genotyping methods & quality control 
In this study, genotyping was performed using iPLEX chemistry on the 
Sequenom MassARRAY platform (Ehrich et al., 2005) in the McGill University and 
Genome Quebec Innovation Center, Canada. 
Figure 2.5 outlines the steps involved in the iPLEX assay. Briefly, DNA 
samples are firstly amplified by PCR, and the products are SAP-treated to 
dephosphorylate unincorporated dNTPs. Single base extension is performed with a 
primer designed to detect sequence differences at the single nucleotide level, which, 
depending upon template sequence, results in an allele-specific difference in mass 
between extension products. The mass difference was then detected by 
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Matrix-Assisted Laser Desorption/ Ionization Time-of Flight Mass Spectrometry 
(MALDI-TOF MS), and in turn differentiated SNP alleles. 
Amptijicanon 
10-finertag 
、forward PGR primer 
5 ——•_EG] 3, 
3. 
Genomic DNA 4 、 








Pr1nr»ef extension into SNP site 
g ^ _ _ 
Printer 』ex t e i y i o n into SNP site 
1 r 




窗， M •痛 wr • «•» _ ’ 
24-ptex spectrum 
Figure 2.5: iPLEX Assay. Adopted from Oeth et al. (2005) 
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DNA samples were diluted to 20 ng/|j,l in extra pure water, and were placed by 
aliquot into each well of a 96-well PCR plate, following the position in a 
pre-assigned schematic layout form. Four wells at specific positions were left empty 
for negative and positive controls provided by the McGill Genome Center. The plates 
of DNA samples were sealed by 8-cap strips, and then covered in bubble wrap for 
shipment. 
Assay design for the selected markers was done by the McGill Genome Center, 
using Assay Design 3.0.0 (Sequenom Inc.) The software assesses the suitability of 
primer design for a marker, by checking GC content, amount of intersperse repeats 
and presence of secondary SNPs within the sequence flanking the marker of interest. 
Validation was done to find the optimal working conditions for the marker of interest 
using a subset of samples. These conditions were then used for the production step in 
the genotyping procedure. If no conditions could be used to rescue failed markers in 
the validation steps, we would be notified and asked to repeat the validation step, 
replace or discard the markers. 
Results were delivered by e-mail in 3 excel files, revealing: 1) the genotype of 
each subject for each marker, 2) marker performance, including MAF, HWE, and 
call rate of each marker, and 3) call rate of each sample. 
Samples successfully genotyped in less than 80% of the markers were excluded 
from analysis. Markers were excluded if they either had a call rate lower than 95%, 
had a MAF lower than 0.01, or deviated significantly from Hardy-Weinberg 
equilibrium (HWE)(p<0.001). The concordance of genotypes among plates was 
checked by an in-house positive control in each plate, which was a DNA sample 
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extracted from a HapMap lymphocyte cell-line. The concordance of genotypes 
between the two genotyping stages was also examined by 15 blind duplicate samples 
2.2.6 Statistical analysis 
Continuous data were expressed as mean 士 standard deviation (SD) or geometric 
mean (95% confidence interval [CI]) and were logarithm transformed if necessary. All 
statistical tests were performed with SPSS 14.0 for Windows (SPSS Inc., Chicago, IL, 
USA) unless otherwise specified. 
Departure of genotype frequencies for each SNP from Hardy-Weinberg 
equilibrium (HWE) was assessed by a x^  test with one degree of freedom (1 d.f.). 
Continuous data including obesity indices (BMI, %Fat, FMI, FFMI, WC, HC, WHtR 
and WHR) and metabolic traits (SBP, DBP, TG, TC, HDL-C, LDL-C, FPG, FINS, 
HOMA-IR, IGF-I, IGFBP-3 and IGF-I/IGFBP-3 molar ratio) were compared among 
genotypes under both additive (1 d.f.), general (2 d.f.), dominant and recessive 
models, using linear regression, analysis of variance (ANOVA) and Student /M;ests 
respectively. Multivariate linear regression analysis was used to assess the 
significance of covariates and adjusted for these confounders (i.e. age and sex) in the 
association of genetic factors with obesity phenotypes. 
. Factor analysis 
Factor analysis is a data reduction technique that, by looking for clumps or 
groups among the inter-correlations of a set of variables, reduces a large number of 
related variables to a more manageable set of factors or components, prior to using 
them in other analyses such as multiple regression and analysis of variance. Thus, 
together with the two-stage design, it could help the quick confirmation of 
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associations for SNPs in this study. Factor analysis was performed using SPSS 14.0 
for Windows (SPSS Inc., Chicago, IL, USA), following the instruction by Pallant 
(2005). It involves four main steps: 
1. Checking for normal distribution assumption and standardization 
Each continuous variable was firstly assessed for normality by plotting a 
histogram to check for a bell-shaped distribution, as well as by examining values of 
skewness and kurtosis. Skewness provides an indication of the symmetry of the 
distribution, with positive values indicating a clustering of scores at the low ends 
(left-hand side of a graph), whereas negative values indicate a clustering at the high 
ends (right-hand side of a graph). Kurtosis, on the other hand, provides information 
about the "peakness" of the distribution, with positive values meaning a peaked 
distribution (clustered in the center) with long thin tails, whereas a value below 0 
means a relatively flat distribution with many cases at the extremes. Variables with 
skewness or kurtosis value greater than 1 were transformed by taking natural 
logarithm. Both the imtransformed and transformed variables were checked to see 
which gave the best normal distribution. Extreme values of the variable were then 
removed, which were defined as >mean+4SD or <mean-4SD. After that, the variable 
was standardized as zero mean and unit variance by regression modeling, with 
adjustment for sex and age. 
2. Assessment of the suitability of the data for factor analysis 
The suitability of the data for factor analysis was then assessed by evaluating 
the strength of inter-relations among the standardized variables. This was done by an 
inspection to the correlation matrix of the variables for evidence of coefficients 
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greater than 0.3. If few factors above this level are found, then factor analysis may 
not be appropriate. 
3. Factor extraction 
Factor extraction determines the smallest number of factors that can be used to 
represent the inter-relations among the set of variables. It was conducted by the 
method of principal components. These components are linear combinations of the 
original variables that are constructed so that each component has a correlation of zero 
with each of the other components. Each principal component is associated with an 
"eigenvalue," which represents the variance in the original variables explained by that 
component (with each original variable standardized to have a variance of 1). The 
number of principal components that can be constructed is equal to the number of 
original variables. In factor analysis, the number of factors is customarily determined 
by retention of only those components that account for more of the total variance than 
any single original variable (i.e., those components with eigenvalues >1). 
4. Factor rotation and interpretation 
Once the number of factors has been determined, the factors were "rotated" to 
determine the composition of factors that has the most parsimonious interpretation in 
terms of the original variables. In factor rotation, "factor loadings," which represent 
- correlations of each factor with the original variables, are changed so that these factor 
loadings are made to be as close to 0 or 1 as possible (with the constraint that the total 
amount of variance explained by the factors remains unchanged). There are two main 
approaches to factor rotation, which can be distinguished by whether they require the 
final set of factors to be independent with one another (orthogonal methods) or by 
.whether they allow factors to be correlated (oblique methods). In the present study, 
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both an orthogonal (Varimax) and an oblique (Promax) rotation method were used. 
Due to the similar results found by both methods and previous related studies having 
used orthogonal methods, results for the Varimax method are presented (Hanson et al， 
2002). In interpretation of factor analysis, the pattern of factor loadings was examined 
to determine which original variables represent primary constituents of each factor. 
Conventionally, variables that have a factor loading >0.4 (or less than -0.4) with a 
particular factor are considered to be its major constituents. Each factor was named 
according to the variables which are its major constituents. 
Factor scores 
Once factors were interpreted, scores of the derived factors were generated for all 
subjects by a regression method. These factor scores could then be tested for 
association with genetic and dietary factors. 
Association testing in two genotyping stages and combined analysis 
In stage 1, SNPs passing the quality control (see Section 2.2.6) were analyzed 
for association with each factor score under an additive model. A p-value less than 
0.05 was considered significant (2-tailed). We prioritized SNPs showing significant 
result(s) for confirmation in stage 2. 
In stage 2，quality control criteria for SNPs were the same as in the first stage. 
Factor score association(s) found for the prioritized SNPs was analyzed. Again, A 
p-value less than 0.05 was considered significant (2-tailed). 
We then combined the genotyping data in both stages for confirmation of 
association results. For the analysis of combined data, statistical significance was 
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defined more stringently as p<0.01 (2-tailed), instead of using the conventional 
p<0.05. Also, to be considered significant, an association had to involve the same 
risk allele in both stages. 
SNPs with associations of factor score(s) in the combined analysis, as well as all 
other selected markers in the same gene, were then examined further for association 
with variables constituting the factor(s), using the described statistical methods. 
Haplotvpe analysis 
Linkage disequilibrium (LD) and haplotype block structure of genes were 
analyzed using Haploview (Barrett et al., 2005). The software calculated several 
pairwise measures of LD, such as D' and r^, and created a graphical representation of 
LD and block structure within a gene (Figure 2.6). A number of different color 
schemes were allowed to represent LD relationships, with D' shown as ranging from 
^ • • 2 » • red to pink to white, while r was shown as ranging from black to grey to white. 
Blocks were defined according to the algorithm of Gabriel et al. (2002). Associations 
of haplotype with obesity-related parameters were examined by WHAP using 
standardized variables adjusted for age and sex (Purcell & Sham, 2006). 
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Figure 2.6: Haploview LD "triangle plot". Adopted from Thorisson et al. (2005). 
2.3 Dietary assessment 
2.3.1 Three-day 24-hour dietary recalls 
Three days of multiple-pass 24-hour dietary recalls were collected to quantify 
foods and nutrients actually consumed by the subjects. The multiple-pass method 
was developed and refined by the United States of Agriculture (USDA) for the 
1999-2000 National Health and Nutrition Examination Survey (NHANES) (Kubena, 
2000). It began with a quick list of everything a subject ate or drank the previous day 
from waking up until going to bed. Next, the subject was asked to provide details of 
the foods eaten in this order: (1) time and occasion of the meals; (2) ingredients of 
the foods; (3) food preparation methods; (4) actual amount of foods eaten and (5) 
place of intake, with the aid of food portion models and a food booklet. The subject 
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was then probed for any forgotten foods and eating occasions, followed by a final 
review on the entire list of foods recorded. 
The three dietary recalls were completed within a seven-day measurement 
period, including two weekdays and one weekend, owing to day-to-day variability of 
certain nutrients intakes (Miller et al, 1991). The first recall was done in person, 
while the second and the third recalls were conducted by telephone, using the same 
multiple-pass technique. The recalls were of three non-consecutive days, as several 
studies suggested that consecutive days may not be independent of one another 
(Larkin et al, 1991). The 24-hour dietary recall forms are in Appendix G. 
The food portion models included a plastic cup (300 ml), a plastic spoon (17 ml), 
a plastic plate (23 cm in diameter) and a plastic bowl (250 ml). The food portion 
booklet was produced for adolescent diets by the Food and Nutrition Science 
Programme, The Chinese University of Hong Kong in 2004 (unpublished). The first 
page of the booklet consisted of pictures of food containers and utensils in different 
sizes. About 200 food items were shown in the booklet, with their photo, name, and 
portion size in grains or milliliters (Appendix H). 
2.3.2 Lifestyle questionnaire 
A locally validated dietary assessment questionnaire was used to obtain 
information on the lifestyle patterns of the adolescents. The questionnaire was 
composed of two parts: i) yes/no questions for daily and weekly dietary habits; and ii) 
ten-point scale for physical activity (see Appendix I) 
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2.3.3 Data management 
Three-day 24-hour dietary recalls 
The nutrient information from the dietary recalls was obtained using the 
Nutrition Data System for Research (NDS-R) program version 4.06_34 (University 
of Minnesota Nutrition Coordination Center, USA). Upon entry of a food name, the 
system guided us though a series of menus that captured descriptive information, 
such as the type or brand name of the food, methods used in food preparation, 
specification of key ingredients in recipes, whether fat and/or salt was added to the 
food, and whether the food was prepared commercially or at home. To facilitate 
quantification of amounts, the system provided various options for describing portion 
sizes specifically in each of the particular food item. In addition, to reduce data entry 
errors the system performed numerous edit checks, such as flagging amounts that 
appeared beyond established maxima. 
Once the foods had been completely described and quantified, the nutrient 
calculations were performed automatically by the system. For local foods not found 
in the database of the system, intakes were calculated with substituted foods of 
similar nutrient content profile. Alternatively, a recipe was created for each missing 
food with a combination of existing items in the database. In this study, the subjects' 
daily intakes of nutrients including total fat, total carbohydrate, total protein, 
cholesterol, saturated fatty acids (SFA), monosaturated fatty acids (MUFA), 
polyunsaturated fatty acids (PUFA), trans-fatty acids (TRANSFA), fibers (total, 
soluble , insoluble), vitamins (A, E, C), minerals (folate, calcium, iron) and 
phytoestrogens (daidzein, genistein, glycitein, coumestrol, biochanin A, 
formononetin), as well as energy (total energy, % calorie from fat, carbohydrate, 
.protein, SFA, MUFA, PUFA, TRANSFA) were retrieved. 
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Lifestyle questionnaire 
All the questions in the lifestyle questionnaire were systematically coded. Data 
were then entered into the computers with the anthropometric and biochemical 
measurements. The same set of data was double entered by two persons followed by 
verification to correct typing errors. 
To assess the healthiness of a subject's lifestyle, a "Dietary Health Score" was 
generated for each subject. It was calculated by adding the marks of all binominal 
questions in part one the questionnaire. For questions about unhealthy habits, a "no" 
response scored one mark and a "yes" response scored zero, conversely, for 
questions about healthy habits, a "no" response scored no marks and a "yes" 
response scored one. Except Questions 2,5,6,7 in the daily section and Questions 8,9 
in the weekly section, all questions were probing for unhealthy lifestyle components. 
Thus, the higher the total score, the healthier the lifestyle of the subject. 
2.3.4 Statistical methods 
Continuous data were expressed as mean 士 standard deviation (SD) or geometric 
mean (95% confidence interval [CI]) and were logarithm transformed if necessary. 
Categorical data were expressed as numbers and percentages. All statistical tests were 
performed with SPSS 14.0 for Windows (SPSS Inc., Chicago, IL, USA) unless 
otherwise specified. 
Continuous data, including daily nutrient intakes, the "Dietary Health Score" 
and physical activity index, were compared between groups (case/control or genders) 
by Student /-tests or the Mann-Whitney U test as appropriate. Categorical data 
including binominal response of the lifestyle questionnaire were compared among 
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groups by x^ tests or fisher exact-tests as appropriate. Partial correlations of intakes 
from dietary recalls in 2004 and 2006 were examined to evaluate relatedness of the 
two recalls. The internal consistency reliability of the lifestyle questionnaire was 
evaluated by the Cronbach's alpha, which indicates high reliability of the 
questionnaire if the value is greater than 0.7. The interactions of genotypes (see 
Section 2.2) with the "Dietary Health Score" and physical activity level were 
analyzed using multiple regression analysis, adjusted for age and sex. A /?-value of 
less than 0.05 was considered significant (2-tailed). 
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Chapter 3 - Results 
3.1 Study cohort 
The adolescent cohort in this study consisted of 960 (45.4%) males and 1,155 
(54.6%) females, with mean age of 16士2 years (range 11-20 years; median 16 years). 
Table 3.1 summarizes the clinical and biochemical characteristics of the 2,115 
subjects in the study cohort. 
3.2 Genetic study 
3.2.1 Subjects 
A total of 981 subjects (46.4%) were randomly selected to represent the 
adolescent cohort in this study. We initially test all of the selected SNPs in 450 
subjects. We then replicate results of those SNPs showing significant association(s) 
in the remaining 531 subjects. As summarized in Table 3.1, the clinical and 
biochemical parameters within two stages were similar, and measurements in the 
random subjects were comparable to those of the whole cohort (p>0.01). 
3.2.2 SNPs selection 
Table 3.2 shows the numbers of SNPs tagged, prioritized and captured in each 
of the 18 candidate genes. A total of 136 SNPs were selected for association tests. 
This included 121 tag SNPs that captured all common variants (MAF>5%) in 
HapMap, and an additional 15 SNPs having previously reported associations with 
obesity- and/or growth hormone-related traits. Information of the SNPs, including 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chapter 3 - Results 
3.2.3 Factor analysis of adiposity in the study population 
Correlations among variables are shown in Table 3.3. For most variables 
correlations were of modest to moderate magnitude (0.2-0.7). Notable exceptions 
were those among BMI, WC, HC and %Fat, and that between TC and LDL-C, which 
were consistently >0.8. On the other hand, correlations of blood pressure variables 
with the others tended to be <0.2. The general pattern of correlations was similar in 
stage 1 and stage 2 subjects. 
Factor analysis in stage 1 subjects 
Among subjects chosen in stage 1, factor analysis identified five factors with an 
eigenvalue >1，and the largest eigenvalue among the remaining components was 0.64. 
These five factors accounted for 81.2% of the variance in the original 13 variables. 
Factor loadings of the original variables with each factor after varimax rotation are 
presented in Table 3.4a. The first factor was strongly correlated with BMI, WC, HC, 
o/oFat and HOMA-IR, as indicated by a factor loading >0.4，contributing 29.1% of 
the variance. Likewise, the second factor was strongly correlated with TC and 
LDL-C (15.9%); the third factor was strongly correlated with SBP and DBP (12.5%); 
the fourth factor was strongly correlated with IGF-I and IGFBP-3 (12.4%), and the 
fifth factor was strongly correlated with TG and HDL-C (11.3%). Thus, these five 
factors can be interpreted as representing body composition, TC+LDL-C, blood 
pressure, IGF-I activity and TG+HDL-C. 
Factor analysis in stage 2 subjects 
Among subjects chosen in stage 2, there were also five factors with eigenvalues 
>1. The largest eigenvalue among the remaining components was 0.72. These five 
factors accounted for 79.0% of the variance in the original variables. Factor loadings 
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after varimax rotation are presented in Table 3.4b. The first factor was correlated 
with BMI, WC, HC, %Fat and HOMA-IR, contributing 28.1% of the variance; the 
second factor was correlated with TC and LDL-C (15.6%); the third factor was 
correlated with SBP and DBP (12.4%); the fourth factor was correlated with IGF-I 
and IGFBP-3 (12.1%), and the fifth factor was correlated with TG and HDL-C 
(10.7%). Thus, similar to the results in stage 1 subjects, the five factors can be 
interpreted as representing body composition, TC+LDL-C, blood pressure, IGF-I 
activity and TG+HDL-C. 
Factor analysis in stage 1 and 2 subjects 
The analysis with both stage 1 and 2 subjects once again revealed five factors 
with eigenvalues >1. The largest eigenvalue among the remaining components was 
0.68. These five factors accounted for 79.8% of the variance in the original variables. 
Factor loading results were comparable with those obtained in separate analyses of 
stage 1 and 2 subjects (Table 3.4c). The five factors can again be interpreted as 
representing body composition, TC+LDL-C, blood pressure, IGF-I activity and 
TG+HDL-C. 
Scores of the 5 derived factors were calculated for association tests (See 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chapter 3 - Results 
Table 3.4: Factor loadings for original variables with rotated factors 
a) Stage 1 subjects (n=450) 
Body T C + Blood IGF-I TG + 
composition LDL-C pressure activity HDL-C 
BMI ^ ^ ^ ^ OJT~ 
WC 0.92 0.03 0.08 0.11 0.10 
HC 0.93 0.00 0.08 0.13 0.00 
SBP 0.22 -0.02 0.82 0.14 -0.04 
DBP 0.05 0.04 0.87 0.03 0.08 
o/oFat 0.88 0.15 0.10 0.06 0.17 
TC 0.06 0.99 0.04 0.02 -0.04 
TG 0.05 0.20 0.10 0.17 0.85 
HDL-C -0.25 0.33 0.09 0.09 -0.74 
LDL-C 0.16 0.93 0.00 -0.05 0.04 
HOMA-IR 0.47 0.14 0.33 0.17 0.37 
IGF-I 0.14 -0.11 0.04 0.87 0.04 
IGFBP-3 OM OM 0.85 0.07 
% variance ^ \2A 11.3 
Factor loadings with an absolute value >0.4 are shown in bold. The percentage of the 
variance represents the proportion of variance in the original 13 variables accounted 
for by the factor. 
b) Stage 2 subjects (n=531) 
Body TC + Blood IGF-I TG + 
composition LDL-C pressure activity HDL-C 
BMI 0.94 0.03 0.08 0.05 0.10 
WC 0.91 0.03 0.10 0.12 0.11 
HC 0.90 -0.01 0.12 0.11 0.02 
SBP 0.27 0.07 0.82 0.01 0.03 
DBP 0.07 0.08 0.87 0.10 0.03 
o/oFat 0.87 0.12 0.10 0.00 0.12 
TC 0.03 0.98 0.10 0.02 -0.09 
TG 0.10 0.32 0.12 0.14 0.75 
HDL-C -0.21 0.26 0.05 0.01 -0.83 
LDL-C 0.11 0.92 0.06 -0.04 0.11 
HOMA-IR 0.46 0.05 0.23 0.22 0.26 
IGF-I 0.13 -0.13 0.06 0.87 0.08 
IGFBP-3 ^ q ^ ^ ^ 0.04 
o/o variance m ]2A 12A 10.7 
Factor loadings with an absolute value >0.4 are shown in bold. The percentage of the 
variance represents the proportion of variance in the original 13 variables accounted 
for by the factor. 
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c) All subjects (n=981) 
Body T C + Blood IGF-I TG + 
composition LDL-C pressure activity HDL-C 
BMI 0.94 0.05 0.10 0.08 0.10 
WC 0.91 0.03 0.09 0.12 0.11 
HC 0.91 0.00 0.10 0.12 0.01 
SBP 0.24 0.03 0.83 0.08 0.00 
DBP 0.06 0.07 0.88 0.06 0.05 
%Fat 0.88 0.13 0.11 0.02 0.14 
TC 0.04 0.99 0.07 0.02 -0.07 
TG 0.07 0.27 0.10 0.16 0.80 
HDL-C -0.23 0.29 0.05 0.04 -0.80 
LDL-C 0.14 0.92 0.04 -0.04 0.08 
HOMA-IR 0.47 0.09 0.27 0.19 0.30 
IGF-I 0.14 -0.12 0.05 0.87 0.06 
IGFBP-3 ^ q ^ q m ^ 0.06 
% variance ^ m 122 11.0 
Factor loadings with an absolute value >0.4 are shown in bold. The percentage of the 
variance represents the proportion of variance in the original 13 variables accounted 
for by the factor. 
3.2.4 Genotyping and association testing in stage 1 
As shown in Table 3.5, thirteen of the 136 SNPs were excluded due to either (i) 
a call rate lower than 95%; (ii) MAF<0.01 in the population (Appendix B); or (iii) 
significant departure from HWE (p<0.001) (Appendix C). Thus, only 123 SNPs 
(90.4%) were analyzed in stage 1. Nevertheless, most of the genes could still attain 
>90% coverage of the common variants. Four (0.8%) out of 450 subjects were 
removed from analysis because of a call rate lower than 80%. Our genotyping 
success rate was 99.80% (54,749 out of 54,858). Based on comparison of genotypes 
in 6 duplicate in-house samples (n=738) with HapMap data, we documented a 








































































































































































































































































































































































































































































































Chapter 3 - Results 
Figure 3.1 illustrated association results of the 123 SNPs with factors scores of 
body composition, TC+LDL-C, Blood pressure, TG+HDL-C and IGF-I activity in 
stage 1. A total of 45 SNPs passed the cutoff at /?=0.05 under an additive model for 
at least one factor. We thus prioritized these SNPs for confirmation in stage 2 (See 
also Appendices A and E). 
3.2.5 Genotyping and association testing in stage 2 
The genotyping performance of the 45 SNPs replicated was comparable to that 
in stage 1. MAF of these SNPs in stage 2 were similar to that in stage 1 and HapMap 
data (Appendix B), and none of them showed significant departure from HWE 
(Appendix C). Four (0.8%) out of 531 subjects were removed from the analyses 
because of a call rate lower than 80%. Our genotyping success rate was 99.42% 
(23,757 out of 23,895), and the consensus rate was 98.52%, based on comparison of 
genotypes in the 6 duplicate in-house samples (n=270) with HapMap data. We also 
documented a concordance rate of 98.07% between two genotyping stages, using 
genotypes of 15 blind duplicate samples (n=675). 
The association results of nine SNPs in five genes: CART, GHR, GHRHR, 
IGFBP3 and POMC with their corresponding adiposity factor(s) will be discussed 
. below (Table 3.6 and Appendix E). 
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Figure 3.1: Graphical summary of stage 1 association results. The x-axis is the 
assigned test number of SNPs (see Appendix A); the y-axis is the log-tranformed 
；?-value under an additive model. The dotted line shows p=0.05. SNPs passing this 
















































































































































































































































































































































































































































































Chapter 3 - Results 
3.2.6 Association of the CART gene with adiposity 
Genetic variation at CART 
The CART gene consists of 3 exons that span 1.88kb of chromosome 5 
(71,050,749-71,052,627 bp). The gene structure of CART and the pairwise LD 
between genotyped SNPs are depicted in Figure 3.2 (See also Appendix A for details 
of these SNPs). The SNP 1475AyG was monomorphic in our study population, while 
the SNP rs3763154 showed significant departure from HWE, so they were excluded 
from analysis. The remaining 8 genotyped SNPs covered 92.3% of all common SNPs 
(MAF>5%) within the gene, with an average genotyping success rate of 99.87% 
(4,614 out of 4,622). 
Association of CART polymorphisms with TC and LDL-C 
Association was found for the SNP rs3763153 with the TC+LDL factor score 
(p=0.0013) (Tables 3.6 & 3.7). The minor G allele of this SNP was associated with 
increased levels of TC and LDL-C under an additive model (p=0.0020 and 0.0014 
respectively). The effect of the allele was closer to dominant (p<0.005) than 
recessive (p<0.05) (Table 3.7). 
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Chf5: 71050749-71052627 
< I I I I I • I I I I I I I I I M i l I • I I ' I • • I M I I I I I I I I I I I I I I I I I I I I I ) 
71049k 71050k 71051k 71052k 71053k 71054k 
Genotyped SNPs 
G 0 R TG G TTC COI G C CO： G TT R c e G c A r G e i t t g a t a a a c g c t 
Entrez genes 
NI1_004291 
Hai » •！ 
CART: cocaine- and amphetamine-regu1ated transcript 
I \ \ ' \ V ^ / I 
ig (O Oi eo (O o o <r-
U5 u> ^ o a> fz g fH 
I I i i s s I ？ 
^ ^ ^ ^ \ t \ 
SNP Position (bp) Major/minor allele MAF HWE p-value 
rs3763155 71049004 G/C 0.154 0.485 
rs3763153* 71049403 A/G 0.350 0.816 
rs3846659 71049929 G/C 0.284 1.000 
rs6894603* 71050374 T/G 0.136 0.351 
rsll575893 71051207 C/T 0.194 0.044 
rs2239670 71051259 G/A 0.255 0.100 
rsl7358300 71053813 T/C 0.451 0.725 
rsl6871471 71054313 A/T 0.115 0.746 
Figure 3.2a: Structure of CART gene and information of SNPs studied. Exons are 
represented by black boxes. The 5' and 3'untranslated regions (UTRs) are 
represented by grey boxes. * Selected for replication in genotyping stage 2 
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Figure 3.2b: Pairwise linkage disequilibrium (LD) between CART SNPs estimated by 
D，(upper block) and r (lower block). Increased color intensity represents increased 

















































































































































































































































































































































































































































































































































































































































Chapter 3 - Results 
Association of CART haplotypes with TC and LDL-C 
We analyzed the haplotypes comprising rs3763153 and rs6894603 in CART. 
The former was the associated SNP with TC and LDL-C, while the latter had trend of 
association (though its association could not be replicated in stage 2 as well as in the 
combined data; see also Appendix E for details). These two SNPs formed three 
common haplotypes with frequency >1%. Haplotype analysis gave similar results to 
that of single markers. The haplotype GT had higher TC+LDL-C factor score 
compared to the other two haplotypes (p=0.0012), which meant the association of 
this haplotype was contributed by rs3763153 alone (Table 3.8). 
Table 3.8: Association of haplotypes containing rs3763153 with TC+LDL-C 
Allele TC+LDL-C 
s 
Haplotype — ^ Frequency 
g I Mean [95%CI] / 
m vo 
1 A T 0.513 -0.081[-0.189,0.027] 0.061 
2 G T 0.350 0.141 [0.043,0.239] 0.0012 
3 A G 0.137 -0.062 [-0.200，0.076] 0.070 
p (2 d . f jb 0.0037 
Haplotypes of >1% frequency were tested for association with factor scores, which 
differences were expressed in standardized coefficient beta. P-values were 
^haplotype-specific (1 d.f.) or ''omnibus (d.f. = Nhapiotypes - 1) 
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3.2.7 Association of the GHR gene with adiposity 
Genetic variation at GHR 
The GHR gene consists of 20 exons that span 297.9kb of chromosome 5 
(42,459,782-42,757,681 bp). The gene structure of GHR’ and the pairwise LD 
between genotyped SNPs are illustrated in Figure 3.3 (See also Appendix A for 
details of these SNPs). SNPs rsl3160458 and rs9292853 were excluded from 
analysis because of call rate <95%. All of the remaining 17 genotyped SNPs were in 
HWE, covering 97.3% of all common SNPs (MAF>10%) within the gene, with a 
genotyping success rate of 99.80% (16,508 out of 16,541). 
Association of GHR polymorphisms with body composition 
There was an association of the SNP rs4410646 with the body composition 
factor score (p=0.0063) (Tables 3.6 & 3.9a). The minor C allele of this SNP was 
associated with lower BMI (p=0.0023), HC (p=0.00082) and FFMI (p=0.0012). 
There was also a trend of association of the C allele with lower %Fat (p=0.028), FMI 
(p=0.016) and WC (/?=0.010). Further analysis under a recessive model strengthened 
the evidence for association of the SNPs with these variables (0.00030< /7<0.0094). 
On the other hand, no association was found with WHtR and WHR (Table 3.9a). 
Association of GHR polymorphisms with blood pressure 
. Further analysis of rs4410416 also revealed evidence of association with blood 
pressure. Although the association was not significant in stage 1, the direction of 
association was the same between stages, that the C allele was associated with lower 
SBP (p=5.93x10-5) and DBP (p=0.00087), and again, its effect was close to recessive 
(Table 3.9b). 
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Another SNP, rs4130113, was also observed to have association with blood 
pressure, albeit insignificant in stage 1. Still, the association involved the same risk 
allele in both stages, with the G allele associated with higher SBP (p=0.00033) and 
DBP (/?=0.0013). However, the effect of this SNP was no longer significant when 
controlled for rs4410416 (p=0.103 for SBP and ；?=0.362 for DBP), indicating that the 
association of GHR with blood pressure was contributed by rs4410416. 
Association of GHR polymorphisms with IGF-I activity 
Association was found for SNP rs7703713 with IGF-I activity (p=0.0074) 
(Tables 3.6 & 3.10). Although the association with the factor score was not 
significant in stage 2，the direction of association between stages was the same. The 
association of rs7703713 remained significant even when controlled for rs4410646 
(p=0.013), indicating that its effect was independent of rs4410646. The minor A 
allele of this SNP was associated with higher IGF-I (p=0.0013). Further analysis 
under a dominant model strengthened the evidence for association of the SNPs with 
these variables (p=0.00069). The A allele carriers also tended to have higher 
IGFBP-3 level (p=0.023) and IGF-I/IGFBP-3 molar ratio (p=0.024) (Table 3.10). 
Association of GHR haplotypes with body composition, blood pressure and IGF-I 
activity 
.. Statistical reconstruction of haplotypes comprising the two associated SNPs 
rs4410416 and rs7703713 identified three common haplotypes of >1% frequency. 
We observed that the haplotype GC had lower body composition and blood pressure 
score than the other two haplotypes (/?=0.0063 and 0.00017 respectively), while the 
haplotype AA had higher IGF-I activity factor score (p=0.0072). However, the 
'significances were similar to that of single markers (Table 3.11) 
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Chr5： 42457782-42759681 
( ' * ' 429001c 426^"* , _ I _ ' ' ' ' 427001c ^ 
Ensenbl mam eNST00000290e«2 
» 1 — — — -rr-'W^^ 
CHR: sroifth hormone rtceptor fr«curs)or 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
Position Major / minor 
Tag# SNP MAF HWE p-value 
(bp) allele 
1 rs2972408 42499366 G/A 0.151 0.519 
2 rs2940917 42503212 G/A 0.149. 0.595 
3 rs4130113 42550408 A/G 0.454 0.591 
4 rsl2153009 42589636 G/A 0.273 0.617 
5 rs7703713 42591688 G/A 0.170 0.702 
6 rs4410646 42605399 A/C 0.390 0.741 
7 rs6898743 42638249 C/G 0.365 0.634 
8 rs4242115 42649642 G/C 0.161 0.009 
9 rs4484445 42650917 A/C 0.164 0.029 
10 rs4554233 42655073 A/G 0.160 0.025 
11 rs7715032 42660552 T/C 0.205 0.476 
rs6179 
12 … ， … ， � 42735801 G/A 0.175 0.517 
(Glyl86Gly) 
rs6182 
13 , , 42754685 G/T 0.151 0.383 
(Cys440Phe) 
rs6180 
14 42754996 C/A 0.409 0.769 
(Ile544Leu) 
rs6184 
15 42755101 C/A 0.150 0.500 
(Pro579Thr) 
16 rs3733838 42757753 T/C 0.154 0.901 
‘ 17 rsl2518414 42757835 G/A 0.233 0.368 
Figure 3.3a: Structure of GHR gene and information of SNPs studied. Exons are 
represented by black boxes. The 5' and 3'untranslated regions (UTRs) are 
represented by grey boxes. 
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Figure 3.3b: Pairwise linkage disequilibrium (LD) between GHR SNPs estimated by 
D, (upper block) and r^ (lower block). Increased color intensity represents increased 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chapter 3 - Results 
3.2.8 Association of the GHRHR gene with adiposity 
Genetic variation at GHRHR 
The GHRHR gene consists of 13 exons that span 15.5kb of chromosome 7 
(30,776,875-30,792,380 bp). Figure 3.4 shows the gene structure of GHRHR, and 
the pairwise LD between genotyped SNPs (See also Appendix A for details of these 
SNPs). All the 9 genotyped SNPs were in HWE. They covered all common SNPs 
(MAF>5%) within the gene, with a genotyping success rate of 99.90% (5,832 out of 
5,838). 
Association of GHRHR polymorphisms with body composition 
There was evidence of association between the SNP rs2302019 with the body 
composition factor score (p=0.0044) (Tables 3.6 & 3.12). Although the association 
was not significant in stage 2, the association involved the same risk allele in both 
stages. The association of this SNP was close to dominant, in that carriers of minor T 
allele of this SNP tended to have higher BMI, %Fat, FMI, FFMI, WC and HC 
(0.0087<j!?<0.056). On the other hand, no association was observed for WHtR and 
WHR (Table 3.12). 
Association of GHRHR haplotypes with body composition and IGF-I activity 
We analyzed the haplotypes comprising rs2302019 and rs4988496 (Ala57Thr) 
in GHRHR. The former was the associated SNP with body composition, while the 
latter had trend of association with IGF-I activity (though its association could not be 
replicated in stage 2 as well as in the combined data; see also Appendix E for details). 
These two SNPs formed four common haplotypes with frequency >1%. We observed 
that the haplotype TA had the highest body composition and IGF-I activity factor 
scores among the four haplotypes (p=0.019 and 0.062 respectively) (Table 3.13). 
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Chr7 
< ‘ ‘ ‘ 1 1 1——I 1——I——I——I——I 1 1 1 1——I 1 lA 
30780k 3 0 7 9 0 k ^ 
NM_000823 
i—~— ‘ — ‘ — — H " " ^ — ~ ~ — 
GHRHR: growth hormone releasing hormone receptor 
l\ \ \\ Zl / I 
C N i c ^ P l S S t J S S C 
O o (D m £ ^ 00 O CM 
SNP Position (bp) Major/minor allele MAF HWE p-value 
rs2302019 30776663 ^ 0.379 0.237 
rs2302021 30776879 C/T 0.166 0.221 
rs2267723 30780182 A/G 0.244 0.987 
rs4988496 
(Ala57Thr) '0781926 G/A 0.079 0.264 
rsl0278927 30783200 C/T 0.079 0.264 
rs2074781 30788770 G/A 0.079 0.250 
rs4988504 30789258 G/A 0.163 0.511 
rs2270026 30791491 T/C 0.241 1.000 
rs6962369 30792545 T/C 0.203 0.888 
Figure 3.4a: Structure of GHRHR gene and information of SNPs studied. Exons are 
represented by black boxes. The 5' and 3'untranslated regions (UTRs) are 
represented by grey boxes. 
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Figure 3.4b: Pairwise linkage disequilibrium (LD) between GHRHR SNPs estimated 
by D' (upper block) and r^  (lower block). Increased color intensity represents 













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chapter 3 - Results 
3.2.9 Association of the IGFBP3 gene with adiposity 
Genetic variation at IGFBP3 
The IGFBP3 gene consists of 5 exons that span 9.02kb of chromosome 7 
(45,725,088-45,734,110 bp). The gene structure of IGFBP3, and the pairwise LD 
between genotyped SNPs are diagramed in Figure 3.5 (See also Appendix A for 
details of these SNPs). SNPs rsl 0255707 and rs2854746 had call rates <95% so they 
were excluded from analysis. All the remaining 5 genotyped SNPs were in HWE. 
They covered 83.3% of all common SNPs (MAF>5%) within the gene, giving a 
genotyping success rate of 99.30% (4,861 out of 4,865). 
Association of IGFBP3 polymorphisms with IGF-I activity 
There was strong association between the -202A/C polymorphism (rs2854744) 
and the IGF-I activity factor score (p=8.06xl0'^ 1.1x10"^ and 1.2x10'^ respectively) 
(Tables 3.6 & 3.14a). Each copy of the minor C allele of -202A/C was associated 
with decreased IGFBP-3 level (p=1.21xl0"^^) and increased IGF-I/IGFBP-3 ratio 
(P=5.22x10-6) (Table 3.14a). 
The SNPs rs2453839 and rs3110697 also showed association with the IGF-I 
activity factor score (P = 8.06x10"^ and 1.1x10'^ respectively) (Table 3.6). However, 
the significance of these two SNPs decreased when controlled for -202A/C (P = 
0.010 and 0.487 respectively), indicating that their associations were probably due to 
their linkage disequilibrium with -202A/C. 
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SNP Position (bp) Major/minor allele MAF HWE p-value 
rsl 3223993 45724470 G/A 0.357 0.902 
rs2453839 45726813 T/C 0.244 0.841 
rs3110697 45728269 G/A 0.270 0.872 
rs6953668 45729115 G/A 0.051 0.494 
rs2854744 
45734315 A/C 0.263 0.715 
(-202A/C) 
Figure 3.5a: Structure of IGFBP3 gene and information of SNPs studied. Exons are 
represented by black boxes. The 5' and 3'untranslated regions (UTRs) are 
represented by grey boxes. 
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Figure 3.5b: Pairwise linkage disequilibrium (LD) between IGFBP3 SNPs estimated 
by D' (upper block) and r^ (lower block). Increased color intensity represents 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chapter 3 - Results 
Association of IGFBP3 polymorphisms with TC and LDL-C 
Further analysis also revealed associations of -202A/C with TC and LDL-C 
levels. Although the association was not significant in stage 1, the direction of 
association for these two SNPs was the same between stages; the C allele of 
-202A/C was associated with reduced TC (p= 0.0056) and LDL-C 0=0.020), and 
the association was close to recessive (Table 3.14b) 
Association of IGFBP3 polymorphisms with TG and HDL-C 
There was association between the SNP rsl3223993 and the TG+HDL-C factor 
score (p=0.0013) (Tables 3.6 & 3.15). The minor A allele of this SNP was associated 
with decreased HDL-C level (p=0.0067), which effect was close to recessive (Table 
3.15). The association of rsl3223993 remained significant even when controlled for 
rs2453839, rs3110697 and rs2854744 (p=0.0044), indicating that its effect was 
independent with other SNPs within the gene. 
Association oflGFBPS haplotypes with IGF-I activity, TC+LDL-C and TG+HDL-C 
Statistical reconstruction of haplotypes comprising the four significantly 
associated SNPs rsl3223993 and -202A/C identified four common haplotypes of 
>1% frequency. We observed that the haplotype GA had higher TG+HDL-C factor 
score than the other three haplotypes (p=0.0017), while the haplotypes AC and GC 
had lower IGF-I activity factor score (p=0.0068 and 4.73 xio"^ respectively). 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chapter 3 - Results 
3.2.10 Association of the POMC gene with adiposity 
Genetic variation at POMC 
The POMC gene consists of 3 exons that span 7.84kb of chromosome 2 
(25,295,372 — 25,303,209 bp). Figure 3.6 depicts the gene structure of POMC, and 
the pairwise LD between genotyped SNPs (See also Appendix A for details of these 
SNPs). All the 5 genotyped SNPs were in HWE. They covered all common SNPs 
(MAF>5%) within the gene, and have a genotyping success rate of 99.63% (3,797 
out of 3,811). 
Association of POMC polymorphisms with blood pressure 
We observed evidence of association between the 8246C/T polymorphism 
(rsl042571) and the blood pressure factor score (p=0.0067) (Tables 3.6 & 3.17). 
Although the association was not significant in stage 2, it involved the same risk 
allele in both stages. The minor T allele of this SNP was associated with higher SBP 
and DBP (p=0.0066 and 0.0082 respectively) (Table 3.17) 
Association of POMC haplotypes with blood pressure 
We analyzed the haplotypes comprising 8246C/T, rs934778 and 1032C/G 
(rsl009338). The former was the associated SNP with blood pressure, while the latter 
two had trend of association (though their associations could not be replicated in 
stage 2 as well as in the combined data; see also Appendix E for details). These three 
SNPs formed four common haplotypes with frequency >1%. Haplotype analysis 
gave similar results. The TCG haplotype, which contained the minor allele T of 
rsl042571, was significantly associated with blood pressure factor score. This meant 
the association of this haplotype was due to 8246C/T alone (Table 3.18). 
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Chr2: 25295372-25303209 




POMC: proopiomelanocortin preproprotein 
1 \ / / I 
厂 CM CO 00 
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SNP Position (bp) Major/minor allele MAF HWE p-value 
rsl042571* 
, 25295538 C/T 0.031 0.757 
(8246C/T) 
rs6713532 25296484 C/T 0.391 0.944 
rs934778* 25300875 T/C 0.137 0.676 
rs3769671 25301804 A/C 0.035 0.834 
rsl009388* 
… … � 25302752 C/G 0.085 0.920 
(1032C/G) 
Figure 3.6a: Structure of POMC gene and information of SNPs studied. Exons are 
represented by black boxes. The 5' and 3'untranslated regions (UTRs) are 
represented by grey boxes. *Replicated in genotyping stage 2. 
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Figure 3.6b: Pairwise linkage disequilibrium (LD) between POMC SNPs estimated 
by D，(upper block) and r^ (lower block). Increased color intensity represents 
increased degree of LD as implemented in Haploview. 
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Table 3.17: Association oiPOMC 8246C/T with blood pressure 
Genotype Mean士SD [95% CI] 
CC CT TT CC CT TT ^ 
Factor score^ 
Stage 1 418 27 0 0.015 [-0.085,0.114] 0.477 [0.086，0.869] - 0.021 
Stage 2 493 34 0 -0.049 [-0.135，0.036] 0.228 [-0.097,0.554] - 0.176 
Combined 911 61 0 -0.020 [-0.085,0.045] 0.339 [0.088,0.589] - 0.0067 
SBP 
Stage 1 418 27 0 118士 12 123士 13 - 0 . 0 4 8 
Stage 2 493 34 0 116士 12 121±15 - 0.107 
Combined 911 61 0 117 士 12 122 士 14 - 0 . 0 0 6 6 
DBP 
Stage 1 418 27 0 72士 10 76士8 - 0 . 0 3 5 
Stage 2 493 34 0 72土9 75士9 - 0.127 
Combined 911 61 0 1 2 ^ ^ - 0.0082 
Variables were expressed in mean士SD or ^geometric mean [95% CI]. Significant 
associations were shown in bold (defined as /?<0.05 for stages 1 and 2, whereas 
/?<0.01 for combined data and also highlighted in red). 
Table 3.18: Association of POMC haplotypes containing 8246C/T with blood 
pressure 
Allele Blood pressure 
H ^ O 
O cj Frequency 
Haplotype ^ ^ ^ Mean [95%CI] / 
S ^ § 
1 C T C 0.870 -0.020 [-0.091,0.052] 0.245 
2 C C G 0.064 0.080 [-0.103,0.262] 0.473 
3 C C C 0.044 -0.091 [-0.312,0.130] 0.417 
4 T C G 0.022 0.400 [0.103，0.698] 0.0096 
p (3 d.f.)b 0.044 
Haplotypes of >1% frequency were tested for association with factor scores, which 
differences were expressed in standardized coefficient beta. P-values were 
^haplotype-specific (1 d.f.) or ''omnibus (d.f. = N h a p i o t y p e s - 1) 
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3.3 Dietary assessment 
3.3.1 Nutrient intakes of the subgroup in 2004 
Table 3.19 summarizes the clinical and biochemical characteristics of the 231 
subjects categorized into two groups by the presence of MES component(s). The two 
groups, the cases with the MES component(s) and controls without, had similar age 
and sex composition. As expected, subjects with one or more MES components had 
higher obesity indices (BMI, WC, HC, WHR), blood pressures (SBP, DBP), TG, 
LDL-C and FPG, while lower HDL-C than the control subjects (/?<0.05). 
Table 3.19: Characteristics of the subgroup subjects with (cases) or without (controls) 
MES components in 2004 
Controls Cases All p 
n 116 115 231 
Female 71 (61.7%) 63 (54.3%) 134 (56.8%) 0.29 
Age (yrs) 16士2 16±2 16±2 0.39 
Height (cm) 160.8士7.6 160.6±8.6 160.7±8.1 0.85 
Weight (kg) 49.3士8.7 59.4±16.4 54.3士 14.0 <0.001 
BMI ( k g W ) 19.0士2.7 22.8士5.3 20.9士4.6 <0.001 
WC (cm) 66土7 74士 12 70.4士 10.7 <0.001 
HC (cm) 88士6 94士 11 90.8士9.2 <0.001 
WHR 0.75 士0.06 0.79士0.07 0.77士 0.06 <0.001 
SBP (mmHg) 116士 11 125士 15 121 士 14 <0.001 
DBP(mmHg) 72 士8 76士 13 74士 11 <0.001 
Fat (%) 19.7 士 6.1 26.1 士9.3 22.9士 8.5 <0.001 
TC (mmol/1) 4.11 士0.65 4.32士0.87 4.22士0.77 0.031 
TG(mmol/l)a 0.84 [0.77-0.90] 1.01 [0.90-1.13] 0.93 [0.86-0.99] 0.032 
HDL-C (mmol/1) 1.55士0.29 1.45士0.28 1.50士0.29 0 . 0 1 5 
LDL-C (mmol/1) 2 . 1 8士 0 . 5 6 2 . 4 3 ± 0 . 8 0 2 . 3 0士 0 . 7 0 0 . 0 0 7 
FPG (mmol/1) 4.71 士 0.37 5.0 士 1.10 4.86 士 0.83 0.008 
Values are either number of subjects, percentage, mean士SD，or ^geometric mean 
[95% confidence interval]. Differences between groups were compared using 
Student r-test or V test 
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Table 3.20: Daily energy and nutrient intakes in case and control groups in 2004 
Controls Cases All p 
Energy intake 
Energy (kcal) 1986.8士673.2 1915.7士787.4 1951.4士731.6 0.27 
% energy from: 
Carbohydrate 52.6 士8.2 52.9士 7.1 52.7 士 7.7 0.79 
Fat 29.8士6.6 29.3 土 6.1 29.5 士6.32 0.54 
Protein 17.4 士 3.4 17.6 士 2.9 17.5 士 3.2 0.74 
SFA 9.0±2.5 8.9±2.4 8.98士2.45 0.73 
MUFA 11.1 士 2.6 10.9 士 2.7 11.1 士 2.7 0.58 
PUFA 6.8 士 2.5 6.7 士 2.4 6.77 士 2.46 0.67 
Macronutrients 
Carbohydrate (g) 258.2士86.2 249.1士93.3 253.7士89.7 0.27 
Fat (g) 67.1 士32.6 64.3士 37.2 65.7士35.0 0.25 
SFA (g) 20.3 土 10.4 19.8±12.4 20.1 士 11.4 0.33 
MUFA (g) 25.1 士 12.3 24.0士 13.6 24.6士 12.9 0.20 
PUFA (g) 15.6±9.9 14.8士 10.3 15.2士 10.1 0.24 
TRANSFA (g) 3.72士2.44 3.26±2.26 3.49士2.36 0.095 
Protein (g) 86.3±32.9 83.4士33.7 84.8士33.2 0.42 
Cholesterol (mg) 302.2士 144.9 333.6士 178.3 317.8士 162.8 0.19 
Total fiber (g) 14.0±8.2 13.4±5.9 13.7士7.2 0.84 
Soluble Fiber (g) 5.32士3.03 5.16士2.52 5.24士2.78 0.99 
Insoluble Fiber (g) 8.53士5.49 8.17士3.73 8.35士4.69 0.74 
Micronutrients 
Vitamin A (lU) 7918.0土7230.0 7837.0士5182.7 7877.7士6280.9 0.59 
Vitamin E (mg) 5.74士2.99 5.11 士2.23 5.43士2.65 0.25 
Vitamin C (mg) 74.8士63.8 73.2士66.7 74.0士65.1 0.90 
Folate ([ig) 463.7士201.4 432.6士 173.7 448.2士 188.4 0.21 
Calcium (mg) 591.1 士301.3 502.0±231.6 546.8士272.0 0.029 
Iron (mg) 15.4士7.0 14.0士5.8 14.7士6.4 0.13 
Daidzein (mg)a 5.37±7.75 3.36±5.85 3.49士2.36 0.060 
Genistein (mg)a 7.51±11.35 4.60士8.36 4.37士6.93 0.050 
Glycitein (mg)a 0.95 士 1.39 0.65士 1.06 6.06士 10.1 0.21 
Coumestrol (mg)a 0.70土2.60 0.19士0.83 0.80士 1.24 0.58 
Biochanin A (mg)a 0.178士 1.267 0.023士0.203 0.45士 1.95 0.30 
Formononetin (mg)a 0.035士0.203 0.015士0.097 0.10士 0.91 0.28 
All values are mean士SD. Differences between groups are compared using Student 
Mest or ^Mann-Whitney U test. 
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No significant differences in daily energy and macronutrient consumptions were 
observed between the two groups (Table 3.20). For micronutrients, however, we 
observed a significantly lower daily intake of calcium in cases than in controls 
(502.0±231.6 vs. 591.1±301.3; /?=0.029). We also observed slightly lower intakes of 
two phytoestrogens, daidzein and genistein, in cases than in controls (p=0.060 and 
0.050 respectively). 
The mean energy intake of this adolescent subgroup, for both sexes, was below 
the RDAs recommended by the PRC Chinese Nutrition Society in 2000. For males 
aged 16, the mean energy intake was 2,262 kcal while the corresponding RDA was 
2,900 kcal; for females with the same age, the mean energy intake was 1,726.7 kcal 
while the corresponding RDA recommended was 2,400. More than 80% of the 
subjects had energy intake less than the RDAs for each sex, but there was no 
significant difference in the proportion by cases and controls (Table 3.21). 
The mean percentage energy intake from carbohydrate of the subgroup (52.7%) 
was slightly lower than that recommended by the WHO in 2003 (55-75%). About 
60% of the subjects did not reach the recommended range, but there was no 
significant difference between cases and controls (Table 3.21). 
The mean percentage energy intake from protein was 17.5%, which was above 
the range recommended by the WHO (10-15%). About 80% of the subjects 
consumed over the recommended value, but again no significant difference was 
found between cases and controls (Table 3.21). 
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Table 3.21: Proportions of subjects meeting the RDA for energy and nutrients in case 
and control groups in 2004 
N (o/o) 
p 
Controls Cases All 
Energy (kcal)^ 
<2,900/2,400* 98 (84.5) 101 (87.8) 199 (86.1) ^ ^^ 
•2,900 / 2,400 18 (15.5) 14(12.2) 32(13.9) ‘ 
o/o energy CHO'' 
<55% 68 (58.6) 75 (65.2) 143 (61.9) 
•55% 48 (41.4) 40(34.8) 88 (38.1) ‘ 
o/o energy PRQb 
<15% 28 (24.1) 21 (18.3) 49(21.2) 
• 15% 88 (75.9) 94(81.7) 182 (78.8) • 
o/o energy FAT'' 
<30% 61 (52.6) 64 (55.7) 125 (54.1) 
•30% 55 (47.4) 51 (44.3) 106 (45.9) • 
o/o energy SFA^ 
<10% 78 (67.2) 75 (65.2) 153 (66.2) 
• 10% 38 (32.8) 40 (34.8) 78 (33.8) • 
Cholesterol^ 
<300mg 64 (55.2) 60 (52.2) 124 (53.7) 
•300mg 52 (44.8) 55 (47.8) 107 (46.3) 
Fiberb 
<24g 108 (93.1) 110(95.7) 218(94.4) 
•24g 8(6.9) 5(4.3) 13 (5.6) ‘ 
Calcium^ 
<1000mg# 106 (91.4) 111 (96.5) 217(93.9) 
• lOOOmg 10(8.6) 4(3.5) 14(6.1) 
^The PRC Chinese Nutrition Society, 2000 recommendation 
bThe WHO, 2003 recommendations 
• *RDAs (ranges) for males and females respectively, at age 16 with light to moderate 
physical activity levels 
#RDA at age 16 
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The mean percentage energy intake from fat and SFA were 29.5% and 9.0% 
respectively, which were close to the maximum proportion recommended by the 
WHO (<30% and <10% respectively). About 50% of the subjects consumed more 
than the recommended value for total fat, while about 30% of the subjects likewise 
exceeded the recommendation for SFA. However, no significant differences were 
observed between cases and controls (Table 3.21). 
The mean daily cholesterol intake (317.8 mg) was above the RDA 
recommended by the WHO (i.e. 300 mg). About 50% of the subjects exceeded the 
recommended value, but no significant difference was found between cases and 
controls (Table 3.21). 
The mean daily total fiber intake (13.7 g) was well below the RDA 
recommended by the WHO (i.e. 24 g). Only 6% of the subjects had consumption 
reaching the recommended value. No significant difference was found between cases 
and controls, however (Table 3.21). 
The mean daily calcium intake was lower than the RDAs recommended by the 
PRC Chinese Nutrition Society (i.e. 1,000 mg at age 16)，albeit a significantly lower 
intake in cases than in controls (502.0 vs. 591.1 mg, /?=0.029). Only 6% of the 
subjects reached the recommended value. Although in concordance with the 
comparison of intake level, that a smaller proportion of case subjects consumed the 
recommended amount, the difference was not significant (3.5% vs. 8.6%, />=0.17) 
(Table 3.21). 
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3.3.2 Nutrient intakes of the subgroup in 2006 
From this adolescent subgroup, 129 out of the 231 subjects were recalled 
successfully (response rate=55.8%). The clinical and biochemical characteristics of 
these 129 subjects are shown in Table 3.22, by the presence of MES component(s). 
Again, the cases and controls had similar age and sex composition. Cases had higher 
obesity indexes (BMI, WC, HC, WHR), blood pressures (SBP, DBP) and TG, as 
well as lower HDL-C than the controls (/7<0.05), but only displayed trends towards 
significant difference in LDL-C and FPG levels were observed (0.05</><0.1). 
Table 3.22: Characteristics of the subgroup subjects with (case) or without (control) 
MES components in 2006 
Controls Cases All p 
n 89 40 129 
Female (%广 52 (58.4%) 27 (67.5%) 79 (61.2%) 0.43 
Age (yrs) 18±2 18±2 18士2 0.99 
Height (cm) 164.3士7.3 162.9士7.9 163.9士7.5 0.33 
Weight (kg) 53.9士7.8 66.8士 15.0 57.9士 12.1 <0.001 
BMI ( k g W ) 20.0士2.4 25.1土5.4 21.6士4.3 <0.001 
WC (cm) 68.3士6.5 80.5±13.1 72.1 士 10.6 <0.001 
HC (cm) 89.7士5.1 98.0士9.0 92.3士7.6 <0.001 
WHR 0.76 士0.06 0.82土0.08 0.78士 0.07 <0.001 
SBP(mmHg) 111 士 10 119 土 13 114 士 11 <0.001 
DBP(mmHg) 69 士8 75士 11 71 士 9 <0.001 
Fat (%) 21.0 士6.2 30.9士 10.1 24.0 士 8.9 <0.001 
TC (mmol/1) 4.12士0.72 4.28士0.93 4.17士0.79 0.30 
TG (mmol/1)' 0.80 [0.74-0.86] 1.39 [1.11-1.66] 0.98 [0.88-1.09] <0.001 
‘ HDL-C (mmol/1) 1.70土0.31 1.41 土0.35 1.61 士0.35 < 0 . 0 0 1 
LDL-C (mmol/l) 2.06±0.62 2.28士0.76 2.13士0.67 0.088 
FPG (mmol/1) 4.56士0.31 4.67士0.40 4.59士0.34 0.090 
Values are either number of subjects, percentage, mean士SD, or ^geometric mean 
[95% confidence interval]. Differences between groups were compared using 
Student Mest or ^x^ test 
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Table 3.23: Daily energy and nutrient intakes in case and control groups in 2006 
Controls Cases All p 
Energy intake 
Energy (kcal) 2081.2士926.4 1799.7±559.3 1993.9±838.1 0.15 
% energy from: 
Carbohydrate 51.1 士7.5 49.3±6.8 50.5士 7.3 0.21 
Fat 30.9 士 6.1 30.6 士4.6 30.8士 5.7 0.77 
Protein 17.7 士 3.0 19.8 士 3.7 18.3 士 3.4 <0.001 
SFA 9.9 士 2.5 9.3 士 2.2 9.7 士 2.4 0.16 
MUFA 11.8 士 2.8 11.6 士 2.1 11.8 士 2.6 0.73 
PUFA 6.2 士 1.9 6.6 士 1.9 6.3 士 1.9 0.25 
Macronutrients 
Carbohydrate (g) 263.7士 131.6 218.7士68.9 249.8士 117.5 0.052 
Fat (g) 73.3 士40.3 62.9士24.7 70.1 士36.4 0.26 
SFA(g) 2 3 . 0 士 11.1 18.8 士 7.7 2 1 . 7 士 10.3 0 . 0 4 3 
MUFA (g) 27.9士 16.2 24.0士9.9 26.7士 14.6 0.30 
PUFA (g) 15.6士 12.4 14.0士7.3 15.1 士 11.1 0.63 
TRANSFA (g) 3.21 士 1.81 2.94士 1.87 3.12士 1.83 0.29 
Protein (g) 90.2 士 41.1 88.0 士33.3 89.5士38.8 0.81 
Cholesterol (mg) 329.7士 171.4 341.8±168.8 333.5士 170.0 0.74 
Total fiber (g) 13.4士7.7 11.9士6.0 12.9士7.3 0.25 
Soluble Fiber (g) 4.03士2.71 3.56士2.02 3.89士2.52 0.40 
Insoluble Fiber (g) 9.25士5.33 8.21 士4.37 8.93士5.06 0.17 
Micronutrients 
Vitamin A (lU) 10309.1 土 17011.4 8729.9士6217.7 9819.4±14535.1 0.89 
Vitamin E (mg) 6.23±7.15 5.06士2.34 5.87士6.09 0.73 
Vitamin C (mg) 82.6±73.7 107.9±234.1 90.4±143.4 0.82 
Folate (^ig) 417.3士 172.8 388.8士 158.6 408.5士 168.4 0.38 
Calcium (mg) 547.1 士234.8 484.3士224.3 527.6士232.6 0.13 
Iron (mg) 14.4士6.1 14.1 士5.6 14.3士5.9 0.91 
Daidzein (mg)a 4.61 士6.50 4.29土4.89 4.51 土6.03 0.92 
Genistein (mg)a 6.09 士9.25 5.55士6.59 5.92土8.49 0.99 
Glycitein (mg)a 0.92 士 1.28 0.96士 1.14 0.93 士 1.23 0.62 
Coumestrol (mg)a 0.53士 1.94 0.11 士0.20 0.40士 1.62 0.29 
Biochanin A (mg)a 0.041 士0.330 0.060士0.368 0.047士0.341 0.86 
Formononetin (mg)a 0.004士0.010 0.002士0.006 0.003士0.008 0.53 
All values are mean士SD. Differences between groups are compared using Student 
厂test or ^Mann-Whitney U test. 
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No significant differences in daily energy and macronutrient intakes were 
observed, except that the percentage of energy contributed by protein was 
significantly higher in cases than in controls (pO.OOl) (Table 3.23). We did not 
observe any significant difference in the intakes of macronutrients and 
micronutrients. Unlike the results of the 2004 data, although the cases also had lower 
calcium and phytoestrogens intakes, the differences were not significant. 
The mean energy intake of this adolescent subgroup, for both sexes, was again 
below the RDAs recommended by the PRC Chinese Nutrition Society in 2000; for 
males aged 18, the mean energy intake was 2,366.4 kcal while the corresponding 
RDA range was 2,400-2,700 kcal; for females with the same age, the mean energy 
intake was 1,758.1 kcal while the corresponding RDA was 2,100-2,300 kcal. About 
70% of the subjects had energy intake less than the RDA for each sex. On the other 
hand, about 20% of the subjects had energy intake exceeding the recommended 
range for each sex. However, there was no significant difference in the proportion by 
cases and controls (Table 3.24). 
The mean percentage energy intake from carbohydrate of the subgroup (50.0%) 
was lower than that RDA proposed by the WHO in 2003 (55-75%). About 75% of 
the subjects did not reach the recommended range, but there was no significant 
difference between cases and controls (Table 3.24). 
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Table 3.24: Proportions of subjects meeting the RDA for energy and nutrients in case 
and control groups in 2006 
N (%) 
p 
Control Case All 
Energy^ 
<2,400 / 2,100* 60 (67.4) 33 (82.5) 93 (72.1) 
2,400-2,700/2,100-2,300 10(11.2) 2 (5.0) 12(9.3) 0.20 
>2,700 / 2,300 19(21.3) 5 (12.5) 24(18.6) 
% energy CHO^ 
<55% 65 (73.0) 32 (80.0) 97 (75.2) ^ ^^ 
•55% 24 (27.0) 8 (20.0) 32 (24.8) • 
% energy PRO^ 
<15% 16(18.0) 2 (5.0) 18(14.0) • 0 % 
• 15% 73 (82.0) 38 (95.0) 111 (86.0) ‘ 
% energy FAT^ 
<30% 34 (38.2) 17(42.5) 51 (39.5) 
•30% 55 (61.8) 23 (57.5) 78 (60.5) ‘ 
% energy SFA^ 
<10% 46(51.7) 24 (60.0) 70 (54.3) 
• 10% 43 (48.3) 16(40.0) 59 (45.7) • 
Cholesterol^ 
<300mg 45 (50.6) 20 (50.0) 65 (50.4) 
•300mg 44 (49.4) 20 (50.0) 64 (49.6) • 
Fiberb 
<24g 84(94.4) 38 (95.0) 122 (94.6) 
•24g 5 (5.6) 2 (5.0) 7(5.4) ‘ 
Calcium^ 
<800mg# 81 (91.0) 36(90.0) 117(90.7) 
• _ m g 8(9.0) 4(10.0) 12(9.3) 
^The PRC Chinese Nutrition Society, 2000 recommendation 
- ^The WHO, 2003 recommendations 
*RDAs (ranges) for males and females respectively, at age 18 with light to moderate 
physical activity levels 
# R D A a t a g e l 8 
, The mean percentage energy intake from protein in the cases was significantly 
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higher than of the controls (19.8 vs. 17.7%,/?<0.001). However, the intakes of both 
groups were above the range recommended by the WHO (10-15%). In concordance 
to the intake level difference, a larger proportion of cases had consumption 
exceeding the recommended range than controls, although the difference only 
showed a trend towards significance (95% vs. 82%,p=0.090) (Table 3.24). 
The mean percentage energy intake from fat and SFA were 30.8% and 9.7% 
respectively, which was close to the maximum intake recommended by the WHO 
(<30% and <10% respectively). Also, about 60% of the subjects consumed over the 
recommended consumption value for total fat, while about 45% of the subjects 
exceed it for SFA. However, no significant differences were observed between cases 
and controls (Table 3.24). 
The mean daily cholesterol intake (333.5 mg) was above the RDA 
recommended by the WHO (300 mg). About 50% of the subjects had cholesterol 
consumption above the recommended value, but there was no significant difference 
between cases and controls (Table 3.24). 
The mean daily total fiber intake (12.9 g) was much lower than the RDA 
recommended by the WHO (24 g). Only 5% of the subjects had consumption 
reaching the recommended value, although no significant difference was found 
between cases and controls (Table 3.24). 
The mean daily calcium intake (527.6 mg) was lower than the RDAs 
recommended by the PRC Chinese Nutrition Society (800 mg at age 18). Only 9% of 
the subjects reached the recommended value (Table 3.24). 
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3.3.3 Lifestyle pattern of the cohort in 2006 
Table 3.25 shows the clinical and biochemical characteristics of the group of 
random subjects by sex. Similar to data in 2003, males had higher obesity indices 
(BMI, WC, HC, WHR) and blood pressures than females (/?<0.05). Obesity indices 
of the subjects increased significantly from 2003 to 2006 (p<0.001), whereas other 
parameters in the two sets of data were comparable. 
Table 3.25: Age, anthropometric and blood component characteristics of the cohort in 
2006 by gender 
Male Female All p 
n (%) 133 (41.7%) 186 (58.3%) 319 
Age (yrs) 18士2 18士2 18士2 0.61 
Height (cm) 168.5士7.5 161.0士6.5 164.1±7.9 <0.001 
Weight (kg) 61.1 士 13.1 53.4士 10.1 56.6土 12.0 <0.001 
BMI ( k g W ) 21.4士4.0 20.6±3.3 20.9土3.6 0.033 
WC (cm) 73.1±9.7 69.4±8.5 70.9土9.2 <0.001 
HC (cm) 91.9士8.4 90.8±6.4 91.2±7.3 0.19 
WHR 0.79 士0.07 0.76士0.05 0.78士 0.06 <0.001 
SBP(mmHg) 120±13 110.7±11.0 114 士 12 <0.001 
DBP (mmHg) 73士 10 69.2±8.3 71 士9 <0.001 
Fat (%) 20.6 土7 . 3 24.4±7.5 22.8±7.6 <0.001 
TC (mmol/1) 4.11 士0.75 4.13土0.72 4.12土0.73 0.81 
TG (mmol/1)' 0.84 [0.77-0.90] 0.83 [0.75-0.90] 0.83 [0.78-0.88] 0.87 
HDL-C (mmol/1) 1.60士0.33 1 . 6 8 ± 0 . 3 2 1 . 6 5 ± 0 . 3 3 0 . 0 3 6 
LDL-C (mmol/1) 2 . 1 4士 0 . 7 0 2 . 0 9 ± 0 . 6 1 2 . 1 1 土0.65 0 . 4 8 
FPG (mmol/1) 4.55士0.28 4.50±0.33 4.52±0.31 0.12 
. Values are either number of subjects, percentage, mean士SD, or ^geometric mean 
[95% confidence interval]. Differences between sexes were compared using Student 
Mest. 
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Table 3.26: Dietary habits of the cohort 
N (%) „ 
Question All 
Yes No 
Daily habits (D) 
L Eggs, ham, bun with butter or margarine, and ^^^ (57 石）134 (42.4) 316 
milk is a full, healthy breakfast 
2. Breakfast every day* 184 (58.6) 130(41.4) 314 
3. Daily, or almost as often: 
a. Intake of meat > a palm of hand 136(43.3) 178 (56.7) 314 
b. Sweet cakes 28 (8.9) 286(91.1) 314 
c. Instant noodles 32 (10.1) 285 (89.9) 317 
d. Candies/chocolate 87 (27.6) 228 (72.4) 315 
e. Potato chips 32(10.1) 284 (89.9) 316 
f. Carbonated drinks 68(21.6) 247(78.4) 315 
g. Sugar-added drinks 181 (57.3) 135 (42.7) 316 
4. g l glass of milk per day* 38 (11.9) 280 (88.1) 318 
5. glass of soymilk per day* 16 (5.0) 302 (95.0) 318 
6. fruits every day* 85 (26.7) 233 (73.3) 318 
7. rice bowls of vegetables per day* 143 (45.3) 173 (54.7) 316 
8. More meat than vegetables in lunch 228 (72.4) 87 (27.6) 315 
Weekly habits (W) 
1. Deep fried food > twice per week 127 (39.9) 191 (60.1) 318 
2. Eating-out > twice per week 178 (56.2) 139 (43.8) 317 
3. White bread only 108 (34.0) 210(66.0) 318 
4. Meats with visible fat > three times a week 75 (23.6) 243 (76.4) 318 
5. Supplements > three times a week 13 (4.1) 305 (95.9) 318 
6. Watch television or use computer > 2 hrs 
216(67.9) 102 (32.1) 318 
per day 
8. Vigorous activity ^ once every two days* 90 (28.3) 228 (71.7) 318 
9. Functional burner/stove and refrigerator* 293 (92.1) 25 (7.9) 318 
. 10. Any day last month not have enough to eat 6 (1.9) 311 (98.1) 317 
The "Dietary Health Score" was calculated by adding the marks of all questions in 
the questionnaire (full mark=23). For all questions (except those marked with an 
asterisk), a "no" response scores one mark whereas a "yes" response scores zero. For 
questions marked with an asterisk, a "yes response scores one mark whereas a "no" 
response scores zero. 
98 
Chapter 3 - Results 
Dietary habits 
The first part of the lifestyle questionnaire assessed the daily and weekly 
dietary habits of the subjects, and the results are given in Table 3.26. Question D9 
and W7 were excluded from analysis, due to interpretation difficulty by the subjects 
and high missing rate respectively. 
Question D1 intended to test for the respondents' knowledge of healthy lifestyle. 
Yet more than half of the subjects answered incorrectly (The answer should be "no"; 
the stated breakfast set is unhealthy since it lacks dietary fiber and has excessive fat). 
For daily habits, more than 40% of the subjects did not have breakfast every day. 
Daily consumption of snacks was common (10-30% of the subjects for cakes, 
candies, instant noodles, potato chips, and soft drinks), especially for sugar-added 
drinks, which was consumed daily by more than half of the subjects. On the other 
hand, few subjects had the habit of drinking milk and/or soymilk everyday ( � 1 0 % 
and 5% respectively). Less than half of the subjects ate enough fruits and vegetables 
everyday (�30o/o and 45% respectively). Also, many of them (45%) consumed large 
amount of meat daily, with even more subjects (>70%) having more meat than 
vegetables in their lunch (Table 3.26). 
Many of the subjects had unfavorable weekly dietary habits, including the 
frequent consumption of fried and greasy foods (-40%), eating white bread only 
(-30%), and dining out at restaurants (-60%) which is usually less healthy then 
dining in. On the other hand, only few subjects (-4%) consumed supplements 
regularly. In addition, most of the subjects (-70%) had a sedentary lifestyle, in that 
they spent much time watching TV and using computer, while only few (<30%) had 
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regular exercise habits. As expected, almost all the subjects had satisfactory 
conditions concerning economic indicators of food security (Table 3.26). 
The open-ended question probed for the improvement of dietary habits that the 
respondent thought to be necessary. One hundred and eighty seven subject responded 
to this question (response rate=58.6%). Most of them suggested eating more fruits 
and vegetables, less meat, having breakfast, as well as less fried and greasy foods 
(53.5%, 14.4%, 6.4% and 5.9% respectively). Other suggestions included drinking 
milk, consumption of supplements, having meals regularly and a more balanced diet. 
The "Dietary Health Score" in males and females were 12.4土2.6 and 13.6士2.6 
respectively, and the difference was significant (p<0.001) (Table 3.26). 
Physical activity 
The second part of the questionnaire assessed the physical activity of the 
subjects, and the results are shown in Table 3.27. Although most of the subjects had 
moderate physical activity levels (mean=4.19), a considerable proportion (-30%) did 
not have adequate exercise habits, especially for the females (-40%). Consistent with 
the proportion comparison, the males had significantly higher physical activity levels 
than the females (PAL: 5.22士2.70 vs. 3.43士2.22,/7<0.001) 
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Table 3.27: Physical activity level (PAL) by gender 
^ N (o/o) 
PAL p 
Males Females Total 
Low (0 - I f 20 (15.3) 62 (35.2) 82 (26.8) 
Moderate (3 - 6 / 69 (53.1) 94 (53.4) 163 (53.3) <0.001 
High ( 7 - 1 Of 41 (31.5) 20(11.4) 61 (19.9) 
Mean士 SDb 5.22 士2.70 3.43士2.22 4.19士 2.19 <0.001 
Values are either number of subjects, percentage or mean土SD. Differences between 
sexes were compared using test or ^Student /-test. 
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Chapter 4 - Discussion 
4.1 The role of GH-related genes with adolescent adiposity 
In this study, based on the augmentation of GH levels in adolescents, the 
previously reported roles of GH and IGF-I in lipid and glucose metabolisms, and the 
interplay of GH with dietary factors, we hypothesized that genes encoding the 
GH/IGF-I axis, as well as those regulating food intake and physical activity, might 
contribute to the modulation of obesity and metabolic perturbations among the young 
population. We did find associations of polymorphisms in several candidate genes 
with obesity-related metabolic traits, which are discussed below. 
Growth hormone receptor (GHR) 
Growth hormone (GH), acting through its receptor GHR, is essential for 
postnatal growth and metabolic homeostasis (Leonsson et al. 1999; Frick et al 2001; 
Rowland et al. 2005). Previous studies showed that GHR gene-deficient (GHR-/-) 
mice exhibit proportional growth retardation, elevated insulin sensitivity, reduced 
islet P-cell mass as well as increases in fat pad weights (Zhou et al. 1997; 
Chandrashekar et al 1999; Liu et al 2004). In both human and animal models, GH 
and GHR are present in regions of the brain known to participate in the regulation of 
. feeding behavior, energy balance, and motivation, including the hypothalamus, 
hippocampus, and amygdala, suggesting their role on feeding regulation (Lai et al 
1991; Lai et al 1993; Lobie et al. 1993; Mustafa et al 1994). Furthermore, rare 
mutations in the GHR gene result in Laron Syndrome, the growth hormone 
insensitivity syndrome which exhibits features comparable to that in GHR-null mice, 
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including growth retardation, as well as notably, truncal obesity, insulin resistance 
and hyperinsulinemia (Laron et al 1993; Laron et al 1994). Because of this 
biological evidence, the GHR gene represents an excellent candidate gene that may 
contribute to the pathogenesis of obesity via the GH/IGF-I pathways. 
The present study offers the first association analysis of common tagging SNPs 
in the GHR gene with adiposity and hormonal parameters. With relatively large 
cohort of adolescents in two-stage genotyping, we found associations of rs4410646， 
an A/C polymorphism located at intron 2 of GHR, with the body composition factor， 
that minor C allele carriers of this SNP was associated with lower BMI, FMI, FFMI, 
o/oFat，WC and HC, as well as lower SBP and DBP than the A allele carriers. In 
addition, minor A allele carriers of rs7703713 had higher IGF-I, and tended to have 
higher IGFBP-3 and higher IGF-I/IGFBP-3 molar ratio than the G allele carriers. 
Thus, our data indicate with few confounding factors the importance of genetic 
influence on body composition and IGF-I activity in these adolescents. 
In this study, the minor C allele of rs4410646 was associated with lower BMI 
and FFMI than the A allele, but its associations with %Fat and FMI were of marginal 
significance. Despite a simple and convenient proxy measure of pediatric obesity, 
there are well-known limitations regarding the use of BMI. Both lean mass and fat 
mass are highly correlated with BMI, such that it acts as a proxy for both but can 
distinguish neither. Of note, relationships between BMI and the fat and fat-free 
components of the body are further complicated by varying growth rates and 
maturity levels in children and adolescents (Daniels et al 1997; Maynard et al. 2001; 
Miller et al. 2004). Percentage fat represents the normalization of fatness for body 
size. Yet it ignores between subject variations in fat-free mass, and thus like BMI, 
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contains information about two different aspects of body composition and cannot 
distinguish effectively between them. In keeping with this notion, some suggest the 
use of the fat-free mass index (FFMI) and the fat mass index (FMI), which allows 
independent evaluation of both fat-free mass and fat mass relative to body size 
(Wells 2001). In this case, this SNP was likely to have association with the body 
fat-free mass, i.e. skeletal mass. 
The C allele of rs4410646 was associated with lower HC but no significance 
was observed for WC, WC/Height and WC/HC ratios. WC provides a good and 
clinically useful measure for abdominal visceral fat which is positively correlated 
with risks of cardiovascular disease and type 2 diabetes (Gower et al. 1999; Weiss et 
al 2003). On the contrary, HC and BMI measurements may be confounded by 
subcutaneous fat and skeletal mass (Snijder et al 2004; Snijder et al. 2005). Studies 
revealed that these two measurements were even found to have a negative correlation 
with metabolic disorders such as glucose intolerance and dyslipidemia, after 
statistically controlling for WC (Snijder et al 2004; Snijder et al 2005). Therefore, 
the SNP was likely to be associated with subcutaneous rather than visceral fat. 
The thriftiness hypothesis proposes that the thrifty tendency, in the form of 
certain genetic traits and intrauterine programming, minimizes energy loss and 
facilitates efficient energy storage in the form of fat during times of hardship to help 
survival, but become disadvantageous during times of abundance, when this 
tendency leads to obesity and related disorders (Neel 1962). This hypothesis is 
supported by the adaptation to placental insufficiency, in which the fetus consumes 
its own substrates to provide energy, and the prolonged reduction in availability of 
substrates results in retarded growth, which in turn enhances survival by reducing 
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energy and substrate expenditure (Simmons 2005). Also, there have been reported 
associations between low birth rate and lower resting metabolic rate (Kensara et al. 
2006). Taking the findings of rs4410646 and the hypothesis together, we postulate 
that variants in the GHR gene might serve as thrifty genetic traits to enhance an 
individual's survival in a "feast and famine" situation by reducing body size and 
energy expenditure, which in turn might affect the individual's body fat proportion 
and distribution. Further studies on larger sample sets, especially those with the 
subjects' dietary consumption and physical activity information, would be helpful to 
verify our conjecture. 
We did not observe association of rs4410646 with IGF-I activity, in spite of 
association of this SNP with lower fat-free and subcutaneous masses as well as lower 
blood pressure. In patients with Laron Syndrome, an autosomal recessive disorder is 
caused by dysfunction of GHR and characterized by marked short stature and low 
IGF-I despite normal or increased levels of GH (Laron et al 1993; Laron et al 1994). 
Of note, GH has potent lipolytic effects to mobilize energy stores and reduce body 
fat (Veldhuis et al 2005). An increased prevalence of hypertension is apparent in GH 
deficiency (Bulow et al 1997), though it is also a frequent complication in 
acromegaly (Bondanelli et al 2001). In addition to stimulating IGF-I expression, GH 
regulates gene expression of other mitogenic factors, some of which are essential for 
normal growth (Le Roith et al 2001). Taking these cues together, there is also the 
possibility that the effect of this SNP with lower fat-free mass results from the 
reduced GH affinity to its receptor, whereas that with less subcutaneous fat mass and 
lower blood pressure might be contributed by higher GH levels in the minor allele 
carriers, although we could not verify this in the present study owing to the absence 
of the GH measurement. 
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Another SNP at intron 2 of GHR, rs7703713, was found to have association 
with both high IGF-I and IGFBP-3 levels, as well as high IGF-I/IGFBP-3 ratio, 
suggesting that the SNP may contribute to the receptor's sensitivity to GH, and in 
turn increasing the amount of total and/or free IGF-I. To our knowledge, previous 
studies on the GHR gene focused mainly on the d3GHR polymorphism that leads to 
the alternative retention or exclusion of exon 3 in the GHR transcript. The d3GHR 
isoform was found to be associated with 1.7 to 2 times more growth acceleration 
induced by GH than the full-length isoform (Dos Santos et al. 2004). Significant 
differences were observed in the frequency distribution of the d3GHR and flGHR 
genotypes between a normally distributed adult height population and short SGA 
children, with the biologically less active flGHR/flGHR genotype being almost twice 
as frequent in SGA patients (Audi et al 2006). Because of the proximity of 
rs7703713, as well as rs4410646，to the d3GHR polymorphism, fine mapping of the 
associated gene region is necessary to localize the causal variant(s) that alter(s) 
GH/IGF-I activity and adiposity. 
Growth hormone-releasing hormone receptor (GHRHR) 
Growth hormone-releasing hormone (GHRH), acting through the GHRH 
receptor (GHRHR), plays a pivotal role in the regulation of GH synthesis and 
secretion in the pituitary. In vitro study showed that the Ala57Thr polymorphism in 
the GHRHR gene was associated with elevated GHRH response by human pituitary 
somatrophinomas (Adams et al 2000). Therefore, we speculate that common 
polymorphisms in this gene might modulate adiposity via alteration of GH release or 
activity. 
In this study, we could not replicate any association for the Ala57Thr 
106 
Chapter 4 - Discussion 
polymorphism. Instead, we observe association of rs2302019, a C/T polymorphism 
located at the 5' UTR of GHRHR, with body composition traits. The minor T allele 
carriers of this SNP tend to have higher BMI, %Fat, FMI, FFMI, WC and HC, while 
in contrast, the major C allele has lower measures of these parameters. Therefore, 
similar to the GHR polymorphisms, we postulate that common SNPs in the GHRHR 
also have a role in influencing body size and fat distribution, possibly by affecting 
the binding of GHRH to its receptor, which in turn may alter GH release as well as 
the subsequent actions in the GH/IGF-I axis. 
Insulin-like growth factor binding protein 3 (IGFBP3) 
In agreement with previous reports in adults (Fletcher et al. 2005), we 
confirmed the strong association of the -202A/C polymorphism of the IGFBP3 gene 
with the IGF-I activity factor comprising of IGFBP-3 and IGF-I. In this relatively 
large cohort of adolescents, C allele carriers of -202A/C gene polymorphism had 
lower IGFBP-3 levels, higher IGF-I/IGFBP-3 ratios and lower TC and LDL-C levels 
than A allele carriers. In addition, carriers of the minor A allele of rsl3223993 had 
lower HDL-C levels and tended to have higher TG levels than the C carriers. This 
SNP was also in close linkage with other SNPs of the nearby IGFBPl gene. 
Although we were not able to confirm our original hypothesis regarding the role of 
these SNPs in obesity-related traits, our data indicate the importance of genetic 
influence on IGF-I activity and lipid metabolism in these adolescents with few 
confounding factors. 
The GH/IGF-I axis is essential for regulating somatic growth and intermediary 
metabolism. Growth hormone promotes protein synthesis and tissue growth and has 
potent lipolytic effects in the mobilization of energy stores and the reduction of body 
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fat (Veldhuis et al 2005). On the other hand, IGF-I exerts insulinomimetic effects by 
promoting energy storage and lipogenesis. Of note, the activity of IGF-I at a cellular 
level is tightly regulated by its binding proteins, especially IGFBP-3 (Jones et al 
1995; Le Roith et al. 2001). The latter is the main binding protein which carries 
IGF-I in circulation and directs it to target tissues. In addition, IGFBP-3 protects 
IGF-I from proteolytic degradation and regulates the binding of IGF-I to its receptor 
(IGFIR) (Jones et al. 1995) while the free IGF-I levels exert negative feedback on 
GH secretion (Le Roith et al. 2001). Although there have been reported associations 
of low GH (Lee et al 1999) and IGF-I ( long et al. 2005) with diabetes and 
metabolic syndrome in adults, we were unable to demonstrate similar 
genotype-phenotype associations in this adolescent cohort. Such discrepancy may be 
due to the marked differences in age which have effect on GH secretion and the 
availability of IGFBP-3 in the present analysis, the latter being more reflective of the 
true IGF-I activity. 
On the other hand, other studies have examined the associations of IGF-I and 
IGFBP-3 with cancer susceptibility. Experimental evidence indicates that IGF-I has 
anti-apoptotic and mitogenic action which promotes tumor growth, while IGFBP-3 
acts as a sequestering agent for IGF-I to protect against cancer development 
(Burtrum et al 2003; Sachdev et al 2003). In humans, higher circulating IGF-I and 
lower IGFBP-3 levels are associated with increased cancer risk (Renehan et al 2004). 
In the present study, C allele carriers of the -202A/C polymorphism had lower 
IGFBP-3 levels and higher IGF-I/IGFBP-3 molar ratios than A carriers. Of note, 
other workers have reported risk association of -202A/C polymorphism with breast 
and prostate cancers (Fletcher et al. 2005). Given the young age of our subjects, the 
clinical significance of our findings can only be clarified by prospective studies. 
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In keeping with the risk association of cancer with -202A/C polymorphism, C 
allele carriers of -202A/C also had reduced levels of TC and LDL-C. Both GH and 
IGF-I can stimulate LDL-C catabolism (Hochberg et al. 1992) and inhibit lipoprotein 
lipase activity (Ottoson et al. 1995). To this end, there are emerging data showing the 
risk association between low LDL-C level and cancer risks. In a recent meta-analysis 
of lipid-lowering clinical trials, patients treated with statins and reached low LDL-C 
levels had increased risk of cancers despite having reduced risk for cardiovascular 
diseases (Alsheikh-Ali et al. 2007). More recently, functional studies on the IGFBP3 
regulatory regions revealed a methylation-dependent binding site for upstream 
stimulating factor (USF) located within the haplotype at the -202A/C and -185T/C 
polymorphisms, which was found to influence the basal and insulin-stimulated 
transcription activity of the IGFBP3 promoter in the human leukocyte (Paquette et al. 
2007). In this respect, USF is one of the candidate genes for familial dyslipidemia 
(Pajukanta et al. 2004) and type 2 diabetes (Ng et al 2005). Taken together, our 
findings point to genetic influence on lipid metabolism via IGF-I activity, which may 
influence future risk of cancers. 
Amongst the SNPs examined in this cohort, the A allele of the rsl3223993, a 
SNP located 3，near IGFBP3, was associated with low HDL-C and high TG levels 
reaching significance for HDL-C. Of note, the rsl 3223993 has strong LD with some 
of the SNPs in the adjacent IGFBPl gene. In this respect, although IGFBP-1 
constitutes only a small percentage of the total pool of circulating IGFBPs, it is 
considered to be the principal acute regulator of IGF-I activity. The activity of 
IGFBP-1 has been shown to be downregulated by insulin and upregulated in 
catabolic states and by other glucoregulatory hormones and cytokines (Conover et al 
1992; Lee et al 1997). The current evidence in the literature on the clinical 
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significance of IGFBP-1 remains conflicting. While some studies have reported low 
IGFBP-1 levels in subjects with obesity, hyperinsulinemia (Nam et al 1997), 
impaired glucose tolerance and cardiovascular risks (Heald et al 2001; Heald et al. 
2002), high IGFBP-1 has been shown to be predictive of cardiovascular mortality 
and morbidity in type 2 diabetes in long term studies (Wallander et al. 2007). 
Irrespective of these findings, our results point to complex interactions amongst the 
regulatory components of the GH-IGF-I axis at a genetic level which in turn may 
influence risk of diabetes, obesity and possibly cancers. To this end, several studies 
have also reported risk associations of low IGF-I and high IGFBP-3 with 
cardiovascular disease (Juul et al 2002; Laughlin et al. 2004). 
Cocaine- and amphetamine-regulated transcript (CART) 
Cocaine- and amphetamine-regulated transcript (CART) is highly expressed in 
the arcuate and paraventricular nuclei of the hypothalamus, areas known to be 
involved in the control of appetite (Douglass et al. 1995; Koylu et al 1997). CART 
is a satiety factor and is closely related to the actions of two important regulators of 
food intake, leptin and neuropeptide Y. Hypothalamic CART mRNA levels are 
decreased in animal models with hypoleptinemic states or after prolonged fasting, 
while the expression in these conditions is restored by leptin administration 
(Kristensen et al 1998). Intracerebroventricular injection of recombinant CART into 
rats inhibits both normal and starvation-induced feeding and blocks the feeding 
response induced by neuropeptide Y. Conversely, an antiserum against CART 
increased feeding in normal rats (Kristensen et al. 1998). These data strongly 
implicate CART as an inhibitor of food intake. 
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Figure 4.1: Pairwise LD between SNPs in the adjacent IGFBP 1 and IGFBP3 genes 
estimated by D' (upper block) and r^ (lower block) (HapMap Han Chinese Data 
Release 22). Increased color intensity represents increased degree of LD as 
implemented in Haploview. The -202A/C polymorphism is marked with black arrow. 
Rsl3223993 and other tagging SNPs genotyped in the present study are marked, 
respectively, with red and black squares. 
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Several rare mutations have been discovered in severe early-onset obese 
subjects (Karvonen et al 1998; Challis et al. 2000; del Giudice et al. 2001). In 
addition, Challis et al. (2000) found two common polymorphisms in the 3' UTR, 
A1475G and A1457A. Carriers of the A1475G variant was found to have 
significantly lower WHR, TG and FINS in a large British population, although the 
association was limited to the male gender. Another study in Pima Indians revealed 6 
polymorphic sites in the 5' UTR, in which the A to G substitution at position -156 
was associated with greater BMI (Yamada et al 2002). In our study, however, the 
A1475G polymorphism was monomorphic, compared with the 8% MAF in the 
British study. We did not replicate the A-156G polymorphism, as this polymorphism 
was not consistently reported in other studies. 
Instead, we found significant association of rs3763153, an A/G polymorphism 
in the 5' UTR at position -1474, with higher TC and LDL-C levels by the G allele. 
As noted above, the effects of CART on food intake and lipid metabolism could be 
mediated by other hormones or neuropeptides such as leptin and neuropeptide Y. It 
has been suggested that leptin acts within the central nervous system on the 
regulation of hepatic cholesterol by its implication in the reverse transport and biliary 
removal of adipose-derived cholesterol (Vanpatten et al 2004). Its level is positively 
correlated with a more atherogenic lipid profile in both humans and animal models 
(Wu et al. 2001; Wortley et al. 2004). On the other hand, studies show that 
neuropeptide Y favors energy storage through enhanced lipoprotein lipase activity in 
white adipose tissues (Billington et al., 1991; 1994). Therefore, it is possible that 
CART might modulate cholesterol in the similar mechanisms as leptin and 
neuropeptide Y. Our finding is further supported by a recently reported association of 
the C-3608T polymorphism (rs7379701) with LDL-C measurements (although not 
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TC) in a French population (Vasseur et al 2007). It would be interesting to examine 
the LD between these two SNPs, as well as investigate their association with levels 
of leptin and other hormones regulating the leptin-CART pathway in order to 
elucidate their effects on cholesterol metabolism. 
Proopiomelanocortin (POMC) 
Proopiomelanocortin (POMC) plays an important role in regulating energy 
homeostasis via the melanocortin signaling pathway (Yeo et al 2000). In the 
hypothalamic arcuate nucleus, upon adiposity signaling such as leptin, the POMC 
propeptide is cleaved by prohormone convertases PCI and PC2 to produce a-, |3- and 
y-melanocyte-stimulating hormones (MSH). These peptides bind to melanocortin 
receptors MC3R and MC4R, resulting in the suppression of food intake (Wardlaw 
2001). Previous studies showed that POMC-wmW mice developed obesity, while 
losing their excess weight and fat mass after treatment with a stable a-MSH agonist 
(Yaswen et al. 1999; Smart et al 2006; Tung et al 2006). 
Several rare mutations in the POMC gene have been identified, which cause 
monogenic, severe, early-onset obesity in humans (Challis et al., 2002; Krude et al.’ 
1998; 2003). A few studies reported the influence of common polymorphisms in 
POMC on obesity phenotypes in less extreme individuals. Haplotype association 
with plasma leptin levels was shown in Mexican-American families; higher plasma 
leptin was observed in the haplotype comprising a present Rsal restriction site and a 
T allele at C8426T (rsl042571) in the 3，untranslated region (UTR) (Delplanque et al. 
2000). This association, however, was not found in French obese siblings (Hixson et 
al 1999). On the other hand, a study with British families observed significant 
association of C8246T and C1032G (rsl009388) in intron 1 with WHR corrected for 
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BMI, i.e. susceptibility to central obesity (Baker et al. 2006) 
In this study, although we did not observe association between genotypes with 
either plasma leptin or body composition, we revealed association of C8246T, but 
not C1032Q with blood pressure; the same T allele of C8246T was associated with 
higher SBP and DBP. Interestingly，members of the British cohort were originally 
ascertained for essential hypertension. It is possible that this SNP modulates both 
body composition and blood pressure via the same mechanism. As proposed by 
Baker et al. (2006), the findings might reflect actions of POMC-derived peptides 
whose effects on adiposity are extrahypothalamic. For instance, a POMC-derived 
peptide called P-lipotropin promotes lipolysis in adipose tissues and is present in 
higher concentration in obese subjects (Cozzolino et al 1996). While its effect on a 
body composition among the young population might interplay with other factors, 
such as GH levels and lifestyle in that both affect lipolysis or lipogenesis. Therefore, 
results confirming of this polymorphism with other study populations, as well as 
further analyses of its effect on the expression of both hypothalamic and 
extrahypothalamic POMC-derived peptides will be necessary. 
In this study, we used factor analysis to reduce the large number of correlated 
adiposity phenotypes into fewer uncorrelated factors and analyzed factor scores 
rather than single variables for association with genotypes. Using this approach, we 
circumvented difficulties in interpreting individual variables, as well as preventing 
false positive association results, based on the assumption that a particular 
association found for an individual variable should also be present in its correlated 
variables (e.g. if association of genotypes was found with BMI, the association 
should also be present with WC and %Fat). As revealed in our study, SNPs 
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associated with a particular factor were also found to have significant association 
with most of the variables constituting the factor. 
One of the notable limitations of factor analysis technique is its dependence on a 
number of somewhat arbitrary criteria, i.e., the threshold chosen for selection of 
number of factors retained, the method of rotation used, and the minimum factor 
loading chosen to designate a variable as a primary constituent of a factor. 
Robustness of a particular solution is best evaluated by whether it is consistent across 
different groups of individuals and different analytic procedures (Hanson et al 2002). 
The present analyses gave very similar results for subjects selected in the two 
genotype stages, and these results were consistent using different procedures for 
factor rotation. Moreover, factor analysis results in the present study showed 
consistency with those in previous studies; excluding growth hormone measurements 
(which were unique in our study), most identified a four-factor solution with factors 
representing body composition, blood pressure, TG with HDL-C and TC with 
LDL-C (Hanson et al 2002). 
However, we observed that caution should be taken when analyzing 
associations with derived factors, since these factors can still provide limited 
information on single variables. One of the most obvious examples concerned the 
derived body composition factor constituting BMI, WC, HC and %Fat. Although 
association was observed for rs4410646 in GHR with body composition factor, the 
variables comprising the factor did not provide sufficient information on body fat 
distribution, which could be indicated by WHtR and WHR, as well as the body 
proportion of lean and fat mass, which could be shown by the use of FMI and FFMI. 
On the other hand, we could not put in all these parameters, as a calculated variable 
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tends to be loaded into the same factor with those variables deriving it, which biases 
the factor analysis. 
We applied a two-stage design for the genetic association study, in which a 
portion of the random subjects were genotyped with all of the selected markers in 
stage 1, and a portion of markers with positive results in the preliminary analysis 
were followed up by genotyping them on the remaining samples in stage 2. This 
approach reduces genotyping cost of the study. On the other hand, unlike the 
standard strategy, which views stage 2 as a replication study and focuses on findings 
that reach statistical significance when stage 2 data are considered alone, we 
analyzed the data of both stages jointly. This alternative strategy proved to have 
increased power to detect genetic associations, despite the need to use more stringent 
significance levels (Skol et al. 2006). 
To our surprise and disappointment, most of the previously reported 
associations for the prioritized SNPs could not be replicated in this study. One of the 
possible reasons was that many initial and replication studies on genotype-phenotype 
association have been reported in populations of European descent. It has already 
been shown that many variants having significant association with disease or traits in 
several studies in one population may not necessarily have the same association in 
another (Chanock et al 2007). For instance, a phylogenetic reconstruction of the 
evolutionary relationships between haplotypes within the TCF7L2 exon 4 LD block 
uncovered two major lineages. The more diverse lineage, HapB, contains all but one 
of the haplotypes carrying rs7903146 T, a subset referred to as HapBT2D. The second 
major lineage. Hap A, consists of a relatively homogeneous cluster of haplotypes, 
noticeably divergent from HapB, that show a 'star-like' pattern of diversity, with a 
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single basal haplotype accounting for 81% of its chromosomes. There is an unusual 
degree of divergence between the HapMap groups in this genomic region, with the 
frequency of Hap A ranging from 10% in Nigerian Yoruba (YRI) to 58% in 
individuals of European ancestry from the Utah pedigree of the Centre d'Etude du 
Polymorphisme Humain (CEU) and 95% in East Asians (CHB+JPT). Thus, unlike in 
populations of European and African ancestry, rs7903146 T (HapBT2D) cannot 
account for a large fraction of type 2 diabetes in East Asian populations, because its 
frequency is only - 2 % in the CHB+JPT HapMap group. Notably, the pattern of 
diversity is suggestive of a positive selective sweep that may have rapidly driven 
HapA almost to fixation in East Asians and to lower frequencies in Europeans and 
Africans (Helgason et al 2007). 
Besides differences in study populations, the lack of reproducibility usually 
implies that either the first report was a false-positive result or that in the second 
study was a false negative attempt at replication. The former is quite common, which 
is a phenomenon known as "winner's curse" (Zollner et al 2007); the first report of 
an association is likely to overestimate effect size, of which only the strongest results 
from a number of tests are reported. Follow-up studies powered to detect an effect 
estimated by the initial report, therefore, often fail to replicate findings. On the 
contrary, we believe that our samples provided sufficient power to detect genetic 
associations explaining � lo /o variance of the tested quantitative traits, as supported by 
the power calculation (see Section 2.2.1). 
Recently, the genome-wide association (GWA) studies provided convincing 
evidence for several gene regions involved in type 2 diabetes and obesity, such as 
TCF7L2’ SLC30A8’ HHEX-IDE, CDKALl, CDKN2A-2B, IGF2BP2 and FTO 
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(Diabetes Genetics Initiative of Broad Institute of Harvard and MIT et al 2007; 
Florez et al 2007; Frayling et al 2007; Hanson et al 2007; Salonen et al 2007; 
Scott et al 2007; Sladek et al 2007; Steinthorsdottir et al 2007; Wellcome Trust 
Case Control Consortium 2007; Zeggini et al. 2007). These studies had several 
common features which pinpointed the essence of a successful genetic association 
study. Firstly, they all used relatively large sample sizes (>18,000). Secondly, all 
studies had well-defined and stringent inclusion criteria for subjects. Thirdly, all 
studies used extensive follow-up with several cohorts. Also, the large number of tests 
(-400,000) means thatp-values of 5x10.7 are needed to provide a study-wide value 
of 0.05 (Frayling 2007). The fat mass and obesity-related {FTO) gene region, for 
instance, was found to have � 1 % explained variance with BMI at j!7-value<10'^ 
(Frayling et al. 2007), whereas most of the associations in the present study were of 
/7-values �10-3 albeit around the same variance was observed. As illustrated in Figure 
4.2，the sample size required to attain 80% power with 1% variance at /j-value of 
0.05 and 10"^  are around 1,000 and 4,000 respectively. Therefore, the GWA studies 
tell us that further studies with larger sample sets are necessary to confirm our 
association results at higher levels of statistical confidence. 
Notwithstanding their robustness to detect novel associations, the GWA studies 
still have certain limitations. Currently, all published GWA studies list only the most 
significant SNPs and their neighboring genes while paying little attention to the rest. 
Thus, genetic variants that confer small disease risks are likely to be missed in the 
most-significant SNPs/genes list after adjustment for multiple testing. Similarly, even 
those variants that confer a larger effect might not always rank the highest among 
hundreds of thousands of markers tested, especially when the sample size is small 
(Williams et al 2007). Also, the "best SNPs/genes" approach ignores the interplay of 
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genes in the same pathway. Therefore, it has been proposed that weights be assigned 
to SNPs in GWA studies according to their biological plausibility, such as 
information on genome-wide linkage (Roeder et al. 2006), prior belief of positive 
findings (Wacholder et al 2004), or prior probability of disease association (Pe'er et 
al. 2006). In keeping with this notion, a recent study has demonstrated the 
applicability of pathway-based approaches, which may incorporate information from 
markers with moderate significance levels to help with the detection of novel 
disease-susceptibility mechanisms in GWA studies (Wang et al. 2007). Of note, 
several GWA studies have reported association of IGF2BP2，which encodes a known 
regulator of insulin-like growth factor 2 (IGF2) with type 2 diabetes (Diabetes 
Genetics Initiative of Broad Institute of Harvard and MIT et al 2007; Scott et al 
2007; Zeggini et al 2007). This finding supports that genes in the GH/IGF/IGFBP 
pathways can serve as candidates for further replication and functional studies. 
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Figure 4.2: A plot showing the sample size required to attain 80% power against the 
explained variance at different significant cutoffs 
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4.2 Nutrient intakes and lifestyle pattern of the adolescents 
Both dietary recalls showed that the mean daily energy intakes of the subjects 
were below the RDAs recommended by the PRC Nutrition Society in 2000，while 
the mean percentages of energy intakes from carbohydrate, total fat and SFA were 
more or less the same as that recommended by the WHO in 2003. Nevertheless, a 
considerable portion of the subjects consumed energy from fat and SFA that 
exceeded the recommended levels, consistent with the results of the lifestyle 
questionnaires, which indicated that a considerable proportion of the adolescents 
consumed snacks and fried and greasy foods frequently. The westernization of diets 
in Hong Kong, particularly with excessive fat-rich snacks and frequent fast foods, 
might worsen obesity problems among the young population. 
Simultaneously, the majority of subjects consumed a percentage of energy from 
protein exceeding the WHO recommended level. This was also consistent with the 
reported frequent consumption of meat among the young population. Yet the effect of 
protein intake on obesity remains controversial. It has been suggested that in 
childhood, a high protein intake stimulates insulin secretion, resulting in adipocyte 
multiplication and fat deposition (Arenz et al. 2004). An increased protein intake 
may also contribute to the development of obesity by inducing higher IGF-I level 
while suppressing GH level, both of which could influence growth and also have 
adverse effects on adipose tissue (Wabitsch et al. 1995; Rolland-Cachera et al 1999). 
On the contrary, a number of studies showed that protein is more satiating than 
carbohydrates and fat, and a high-protein diet (30% energy as protein) can result in 
significant losses in weight and body fat (Due et al. 2004; Weigle et al 2005). The 
mean percent energy intake from protein was observed to be higher in cases than in 
controls, but the significance was found only from intake data in 2006. However, 
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both the mean daily intakes of carbohydrate, fat and protein in cases were lower than 
in controls. The observation might have been due to some under-reporting of 
consumption, as this is common in overweight and obese subjects when reporting 
food intake data (Kubena 2000). Also, considering the small sample size of the 
dietary recall subgroup, this association was probably a statistical artifact. 
The mean daily fiber intakes of the subjects in both dietary recalls were far 
below the recommended WHO amounts, which was also supported by the results of 
the lifestyle questionnaire, in that most of the adolescents also reported consuming 
low amounts of fruits and vegetables. Dietary fiber promotes satiation and prolongs 
satiety (Burton-Freeman 2000), thus playing a beneficial role in energy intake 
regulation as well as reducing risk of obesity. 
From the dietary recall data in 2004, the mean daily intake of calcium was 
observed to be significantly higher in controls than in subjects with one or more 
metabolic abnormalities, while the association was not significant from data 
collected in 2006. Yet, the majority of both case and control subjects at both time 
points of data collection did not meet the recommendation for calcium intake. 
Results from the lifestyle questionnaire also revealed that most of the adolescents did 
not have daily habit of drinking milk, which is a rich source of dietary calcium. 
Calcium is an essential mineral which intracellular concentration in adipocytes 
regulates lipogenesis (Xue et al 2001). It has been suggested that a low calcium 
intake stimulates dihydroxyvitamin D and parathyroid hormone secretion that cause 
increased calcium uptake (Zemel et al 2000). The rise in intracellular calcium 
promotes lipogenesis and reduces lipolysis, resulting in an increase in fat tissue mass 
because of lipid filling and adipocyte hypertrophy (Shi et al 2000). However, the 
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role of calcium in the modulation of adiposity among the young population remains 
uncertain. Several observational studies have shown, however, an inverse 
relationship between calcium and/or dairy intake and obesity in children and 
adolescents (Camith et al 2001; Novotny et al 2003), while most showing no effect 
of the intake on weight or body fat change (Chan et al 1995; Phillips et al. 2003; Lin 
etal 2004). 
Based on the "Dietary Health Score" calculated from all the questions about 
daily and weekly eating and exercise habits in the lifestyle questionnaire, the females 
were found to adopt healthier lifestyle scores than the males. However, the males 
were physically more active than the females, as revealed by a higher mean physical 
activity level, which might be due to difference in weight-related concerns and 
behaviors between genders; males are more concerned about whether they look 
masculine enough while females would prefer to be lighter which may make them 
eat healthier in order to control weight and look healthy (Wong et al 2006). 
There was only low but usually positive correlation between the data collected 
from the two dietary recalls in 2004 and 2006; the correlation coefficients for all 
dietary intakes were below 0.3. This emphasizes that dietary patterns do track 
throughout adolescences once habits are established. On the other hand, the weak 
correlation, as well as inconsistency of findings between the dietary recalls in this 
study, was more likely due to a small sample size which limited the power of our 
association analyses. 
We did not find any significant interaction between GH-related genes and 
lifestyle factors, despite the well-established interplay of growth hormone with diets 
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and physical activity on modulating obesity risk. We used the "Dietary Health Score" 
and physical activity rank from the lifestyle questionnaire to represent a subject's 
healthiness in lifestyle. Yet the internal consistency of questions in the questionnaire 
was low with the Cronbach's alpha of only -0.5, indicating that the questionnaire had 
low reliability in interpreting one's lifestyle, and this might be a possible contributing 
factor for the negative findings. 
4.3 Conclusion of this study 
We revealed some associations of genes coding for GH-related pathways in the 
modulation of adiposity among Hong Kong Chinese adolescents. Also, the majority 
of the cohort was observed to have unhealthy diet and lifestyle habits, which might 
further exacerbate their risks for obesity-related metabolic perturbations. Further 
studies on the interactions among these genetic and dietary factors in a larger 
population are needed, in order to better understand the development of obesity and 
related metabolic disorders among the young population in the future so as to find 
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Appendix D: Factor score coefficient matrix 
(I) Stage 1 subject (n=450) 
Body TC + Blood IGF-I TG + 
composition LDL-C pressure activity HDL-C 
BMI 0.277 -0.015 -0.035 -0.038 -0.059 
WC 0.278 -0.036 -0.057 -0.029 -0.067 
HC 0.293 -0.055 -0.050 -0.011 -0.141 
SBP -0.021 -0.040 0.536 -0.039 -0.076 
DBP -0.088 -0.018 0.596 -0.090 0.017 
Fat 0.250 0.027 -0.045 -0.063 0.001 
TC -0.036 0.489 -0.014 0.014 -0.014 
TG -0.141 0.115 0.016 0.048 0.637 
HDL -0.011 0.160 0.087 0.106 -0.526 
LDL -0.001 0.454 -0.047 -0.037 0.035 
HOMAIR 0.149 0.047 0.047 0.010 0.203 
IGFl -0.041 -0.055 -0.093 0.593 -0.042 
IGFBP3 -0.066 0.043 -0.035 0.568 -0.007 
(II) Stage 2 subjects (n=531) 
Body TC + Blood IGF-I TG + 
composition LDL-C pressure activity HDL-C 
BMI 0.295 -0.012 -0.046 -0.075 -0.065 
WC 0.272 -0.017 0.006 -0.063 -0.050 
HC 0.285 -0.034 -0.003 -0.034 -0.125 
SBP -0.027 -0.054 -0.079 0.567 -0.024 
DBP -0.105 -0.052 -0.014 0.624 -0.012 
Fat 0.265 0.034 -0.080 -0.054 -0.028 
TC -0.013 0.502 0.027 -0.037 -0.083 
TG -0.111 0.129 0.018 0.011 0.592 
HDL 0.038 0.121 0.084 0.050 -0.623 
LDL -0.010 0.478 -0.039 -0.063 0.088 
HOMAIR 0.076 -0.013 0.069 0.078 0.136 
IGFl -0.034 -0.063 0.565 -0.023 -0.039 
IGFBP3 -0.040 0.055 0.565 -0.067 -0.031 
170 
Appendices 
(III) All subjects (n二981) 
Body TC + Blood IGF-I TG + 
composition LDL-C pressure activity HDL-C 
BMI 0.286 -0.015 -0.054 -0.043 -0.063 
WC 0.274 -0.026 -0.063 -0.008 -0.056 
HC 0.288 -0.044 -0.042 -0.008 -0.130 
SBP -0.026 -0.050 0.556 -0.056 -0.046 
DBP -0.097 -0.033 0.613 -0.056 0.001 
Fat 0.259 0.028 -0.049 -0.075 -0.015 
TC -0.024 0.498 -0.026 0.021 -0.055 
TG -0.125 0.125 0.011 0.032 0.616 
HDL 0.016 0.135 0.058 0.098 -0.583 
LDL -0.006 0.469 -0.052 -0.040 0.065 
HOMAIR 0.104 0.015 0.062 • 0.046 0.160 
IGFl -0.037 -0.058 -0.056 0.581 -0.045 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Appendix Fl: Consent form (English version) 
Department of Medicine and Therapeutics 
The Chinese University of Hong Kong 
Diabetes, Obesity and Cardiovascular Risk Factors in Hong Kong Adolescents 
Information Sheet and Consent Form (Part 1) 
In 2003-4, both you and your child have kindly agreed to participate in a survey conducted by the 
Chinese University of Hong Kong, which aimed to document the pattern of cardiovascular risk profile in 
Hong Kong adolescents. We hope to invite your child to participate in a follow up survey in 2006-07 that 
should give us important information on the progression of these risk factors. 
Apart from taking body measurements including body height, weight and fat percentage, 10 ml of 
blood and a sample of urine will be collected from your child. He/she will be asked to complete a 
questionnaire on diet and exercise (see attached). 
Both conventional and non-conventional cardiovascular risk factors will be measured in blood and 
urine samples which will be correlated with various lifestyle factors. These data will help our health care 
workers and educators to design programs to promote the general fitness of our adolescents. All data will 
be analyzed in an anonymous manner and used for research and education purposes. Your assistance in 
this important program in our attempt to improve the health and quality of life of our local population is 
much appreciated. 
Professor Juliana CN Chan 
Professor of Medicine and Therapeutics 
June 2006 
Parental and Adolescent Consent form 
1 agree/disagree* to my child participating in the survey 
Name of child 
Name of parent / guardian* 
Relationship with child 
2 Contact telephone numbers 
Address 
Signature of parent / guardian* 
I agree/disagree* to participate in the survey 
Signature of child 
*delete as appropriate 
207 
Appendices 
Information Sheet and Consent Form (Part 2) 
Diabetes, obesity and cardiovascular risk factors are very common in Hong Kong and are now 
affecting an increasingly young population. This is in part due to our rapid changes in lifestyle which 
interact with genetic factors in predisposed individuals. Discovery of these genetic factors will greatly 
improve our understanding of the mechanisms underlying the development of these complex diseases and 
lead to more accurate diagnosis and better treatment. Since 1995, the Chinese University of Hong Kong 
has been leading an applied genomics program to unravel the nature of these gene-environment 
interactions in the development of these chronic diseases. 
Against this background, we are writing to seek your consent to allow the research team to use 
genetic materials extracted from the blood collected from your child to perform genetic analysis relevant 
to diabetes and obesity research. All these information will be strictly analyzed on an anonymous basis 
and will only be used for research and education purposes. 
For any genetic markers identified from this research program, there is a possibility that they may be 
patented for development of new diagnostic tests or drugs for the treatment of diabetes, obesity or related 
diseases. Part of the financial benefits generated from these patented information will go to the Hong 
Kong Foundation for Research and Development in Diabetes established under the auspices of the 
Chinese University of Hong Kong to promote diabetes research and education programs to benefit the 
public and patients. Your consent and assistance in these important health promotion and research program 
will be deeply appreciated. 
Professor Juliana CN Chan 
Professor of Medicine and Therapeutics 
January 2006 
Parental and Adolescent Consent form 
I agree/disagree* to my child participating in the genetic survey 
Name of child 
Name of parent/guardian* 
Signature of parent/guardian* 
I agree/disagree* to participate in the genetic survey 
Signature of child 
*delete as appropriate 
208 
Appendices 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































If  • 作 
合 
的  如  ^ 
謝 
謝 L 
.、  J 
Appendices 
Appendix II: Lifestyle questionnaire (English version) 
The Chinese University of Hong Kong 
Diabetes, obesity and cardiovascular risk factors in Hong Kong adolescents 2006-07 
Lifestyle questionnaire 
SCH ID (Office use only): Name(Chinese): (English): Date: 
Part 1: The following questions test for your dietary habits. Please think carefully about each question 
and answer it according to your situation. 
Daily eating pattern Yes No 
.. Eggs, ham, bun with butter or margarine, and milk is a full, healthy . . . , 
) breakfast. 
2) I have breakfast every day, [ ] [ ] 
3) I eat the following foods daily, or almost as often: 
• Meat sizes larger than the palm [ ] [ ] 
• Sweet cakes or creme cakes [ ] [ ] 
• Instant noodles [ ] [ ] 
• Candies, chocolates [ ] [ ] 
• Potato or other crisps [ ] [ ] 
• Carbonated drinks (cola, etc.) [ ] [ ] 
• Sugar-added non-carbonated drinks (lemon tea, milk tea, 丨 1 丨 ^ 
soymilk, etc.) 
4) I drink >= 1 glass of milk per day. [ ] [ ] 
5) I drink >= 1 glass of soymilk per day. [ ] [ ] 
6) 1 eat >= 2 fruits every day (apple/orange size)s [ ] [ ] 
7) I eat >= 2 rice bowls of vegetables per day. [ ] [ ] 
8) In school days my lunch usually has more meat than vegetables [ ] [ ] 
9) I eat meat sizes larger than 3 mahjong blocks per day. [ ] [ ] 
Weekly eating / lifestyle pattern Yes No 
I eat deep fried food (French fries, fried chicken, spring rolls, etc.) more 丨 1 ^ , 
than twice per week. L J 
2) I eat fast food from a restaurant more than twice per week. [ ] [ ] 
3) I eat only white bread, and never eat whole wheat bread. [ ] [ ] 
I eat meats with visible fat, or poultry with skin more than three times a 丨 1 , , 
^ week. L � L J 
I take supplements more than three times a week. ^ , ^ , 
(If yes, which type? ) L L J 
1 watch television/videos or play on the computer in total more than 2 . , , , 
^ hrs/day. L J L J 
7) I use computer or play on the computer in total more than 2 hrs/day. [ ] [ ] 
g. I run or have other vigorous activity that makes me breathe hard and 丨 1 
makes my heart pound at least once every two days. J 
9) I have both a working bumer/stove and refrigerator where I live. [ ] [ ] 
,Qx Were there any day last month when your family didn't have enough food ^ , . , 
to eat or money to buy food. ^ 
What improvement do you think should be done on your dietary habit? 
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Part 2: The following questions are about your exercise habits ° Please choose one rank which 
represents the amount of exercise you do per week last year，and fill in the box below: 
(Pis refer to the appendix below for examples for low, moderate & high exercise intensity) 
From the ranking 0-10，choose one rank to fill in this box 
For no exercise habits, choose 0 to 2 
0 — entirely no exercise，mainly sit or sleep 
1 — No exercise except little activity in PE lessons 
2 — No exercise except active participation in PE lessons 
For occasional exercise habits besides in PE lessons, choose 3 to 6 
3 一 At least 20 min low intensity exercise 1-2 times per week* ( 3 METs#) 
4 一 At least 20 min low intensity exercise >= 3 times per week 
5 — A t least 20 min low intensity exercise almost everyday 
6 — A t least 20 min moderate to high intensity exercise 1-2 times per week* ( 5 METs ) 
For usual exercise habits besides in PE lessons, choose 7 to 10 
7 — Moderate intensity exercise 3-5 times per week (>= 20 mins each time) 
8 — Moderate intensity exercise almost every day (>= 20 mins each time) 
9 — High intensity exercise for less than 3 times per week* ( 9 METs ) 
(>=20 mins each time) 
10 — High intensity exercise for almost every day (>= 20 mins each time) 
•Appendix: examples for low, moderate & high exercise intensity 
Low intensity Moderate high 
#(3METs) ^(SMETs) ^(9METs) 
House Walk inside home/ move Carry 1-15 pounds stuffs Move furniture/ large-
activities stuffs in home upstairs sized stuffs upstairs 
Go downstairs Mixed going upstairs & 
downstairs 
Stand and play with low In house exercises, e.g. Vigorous exercises 
intensity at home callisthenics, sit-up (exhausting push-up) 
Doing housework, e.g. floor Floor brushing by hands or 
brushing, cleaning with kneeling ； harsher 
vacuum cleaner or cleaning housework，e.g. window 
the house cleaning/ car wash 
Sports Swimming for amusement Routine swimming 
activities Bowling Basketball practice (e.g. Vigorous basketball 
shooting continuously) competition 
Volleyball (one ball for 6-9 Badminton practice Vigorous football 
persons) (single/double) competition 
Archery Cycling; mixed jogging & Faster than usual jogging 
walking (quite exhausting ； Run 
in speed 5.2mph 
(11.5min/mile) 
Play flying saucer Playing in amusement park Cross-country 
Dance in dancing room Dancing (gymnastics of Orienteering 
(e.g. slow dance, waltz) low i m p a c t � f o l k dance in PE 
lessons) 
Others Guitar (standing) 
[Orchestra (parade) 
#METs is a measurement for energy consumption, 1 MET represents sedentary consumption, 
3METs represents 3 times of sedentary consumption, 6METs is 6 times...etc 
End of Questionnaire. Thank you! 
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學生編號（由硏究員塡寫): 姓名(中文): (英文): 日期: 
第一部分:以下是有關你的飲食習慣，請仔細想清楚並回答每條問題。 
每天的飲食習fM S ^ 
~ 0蛋、火腿、塗了牛油或植物牛油的小圓麵飽及奶，稱得上是一份 n T T " 
豐富健康的早餐。 
2) 我每天都吃早餐。 [ ] [ ] 
3) 我差不多每天都吃： 
•多於一隻手掌般大的肉 > [ ] [ ] 
• 甜糕餅或忌廉蛋糕 ‘ [ ] [ ] 
• 即 食 麵 . 二 ” ， [ ] [ ] 
•糖果和朱古力 [ ] [ ] 
•薯片或其他油炸脆片 -.....- [ ] [ ] 
•有汽飲品〔如可樂〕 [ ] [ ] 
•含糖的無汽飲品〔如檸檬茶、奶茶、豆奶等〕 [ ] [ ] 
4) 我每天都喝多於一杯牛奶。 [ ] [ ] 
5) 我每天都喝多於一杯豆奶。 [ ] [ ] 
6) 我每天都吃兩個或以上的水果〔蘋果或橙般大小〕。 [ ] [ ] 
7) 我每天都吃兩碗或以上的蔬菜。 [ ] [ ] 
~~~在上學的日子，我的午餐通常都是肉多於菜。 n f T " 
~ 9 )我每天都吃多於三隻麻雀般大小的肉。 n f T " 
每週的飲食及生落 _ i ^ 
T)我每星期都吃多於兩次油炸食物〔如薯條、炸雞、春卷等〕� n r T ~ 
2) 我每星期都到餐廳吃快餐多於兩次。 [ ] [ ] 
3) 我每星期都只吃白麵包，而從不吃全麥麵包。 [ ] [ ] 
4) 我每星期都吃有肥膏的肉或連皮的家禽多於三次。 [ ] [ ] 
5) 我每星期都服用營養補充劑多於三次。 [ ] [ ] 
(如是’請問是哪種？ ) 
6) 我每日平均花多於兩小時看電視/影帶或玩電腦遊戲。 [ ] [ ] 
7) 我每日平均花多於兩小時使用電腦或玩電腦遊戲。 
8) 我最少每兩天便會跑步一次或做其他會令我呼吸急速和心跳加快 [ ] [ ] 
的劇烈運動。 
9) 我居住的地方同時有煤氣爐/火爐和雪櫃的設備。 [ ] [ ] 







從下表0-10的等級中，只選一等級塡入此方格 � I 





3 —每星期都有一至兩次2 0分鐘以上低強度運動* ( 3 M E T s # ) � 
4 —每星期都有三次以上2 0分鐘以上低強度運動。 
5 —差不多每天都有一次2 0分鐘以上低強度運動。 




9 —每星期都有不多於三次劇烈運動* (9METS)(每次20分鐘或以上）。 
10 -差不多每天都有劇烈運動(每次20分鐘或以上）。 
*附表：低強度、中等強度、及劇烈運動的例子 
低強度運動 中等運動 劇烈運動 
\3METs) 料(5METS) ^(9METs) 
家居活動在家中行走及搬動家居用提取 1 - 1 5膀的物品步行上將像傲或大型家居搬運 






體育運動 嬉戲型式的游泳 不斷來回型式的游泳 
保齡球 _練習 (如不斷射藍） 劇烈的藍球比賽 






玩飛碟 於遊樂場遊玩 越野跑步 
於舞蹈室內的舞蹈 舞 蹈 （ 低 衝 擊 性 的 健 康 野 外 定 向 
(如慢舞或華爾兹） 舞、體育課的土風舞) 
其他一他 (站立） — 
[t弦樂隊(步操） 
# M E T s是能量等値單位 ’ 1 M E T是靜止時能量消耗 ’ 3METS即能量消耗爲靜止時的3倍， 
問卷完畢’多謝合作 
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